EP2341859B1 - Appareil d'ablation de tissus - Google Patents

Appareil d'ablation de tissus Download PDF

Info

Publication number
EP2341859B1
EP2341859B1 EP09819726.2A EP09819726A EP2341859B1 EP 2341859 B1 EP2341859 B1 EP 2341859B1 EP 09819726 A EP09819726 A EP 09819726A EP 2341859 B1 EP2341859 B1 EP 2341859B1
Authority
EP
European Patent Office
Prior art keywords
ablation
positioning element
catheter
tissue
positioning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP09819726.2A
Other languages
German (de)
English (en)
Other versions
EP2341859A4 (fr
EP2341859A1 (fr
Inventor
Virender K. Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP16205336.7A priority Critical patent/EP3175805A1/fr
Publication of EP2341859A1 publication Critical patent/EP2341859A1/fr
Publication of EP2341859A4 publication Critical patent/EP2341859A4/fr
Application granted granted Critical
Publication of EP2341859B1 publication Critical patent/EP2341859B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/24—Surgical instruments, devices or methods, e.g. tourniquets for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00022—Sensing or detecting at the treatment site
    • A61B2017/00084—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00029—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
    • A61B2018/00279—Anchoring means for temporary attachment of a device to tissue deployable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00482—Digestive system
    • A61B2018/00488—Esophagus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577—Ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00791—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B2018/044—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
    • A61B2018/048—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid in gaseous form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04—Constructional details of apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1076—Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions inside body cavities, e.g. using catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3331—Pressure; Flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3368—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1011—Multiple balloon catheters

Definitions

  • the present invention relates to medical apparatus and procedures. More particularly, the present invention relates to a device for ablation of tissue in a hollow organ comprising a centering or positioning attachment in order to position the device at a consistent distance from the tissue to be ablated.
  • Colon polyps affect almost 25% of the population over the age of 50. While most polyps are detected on colonoscopy and easily removed using a snare, flat sessile polyps are hard to remove using the snare technique and carry a high risk of complications, such as bleeding and perforation. Recently, with improvement in imaging techniques, more flat polyps are being detected. Endoscopically unresectable polyps require surgical removal. Most colon cancer arises from colon polyps and, safe and complete resection of these polyps is imperative for the prevention of colon cancer.
  • Barrett esophagus is a precancerous condition effecting 10-14% of US population with gastro esophageal reflux disease (GERD) and is the proven precursor lesion of esophageal adenocarcinoma, the fastest rising cancer in the developed countries. The incidence of the cancer has risen over 6 fold in the last 2 decades and mortality has risen by 7 fold. The 5-year mortality from esophageal cancer is 85%. Ablation of Barrett epithelium has shown to prevent its progression to esophageal cancer.
  • GSD gastro esophageal reflux disease
  • Dysfunctional uterine bleeding (DUB), or menorrhagia affects 30% of women in reproductive age. These symptoms have considerable impact on a woman's health and quality of life. The condition is typically treated with endometrial ablation or a hysterectomy. The rates of surgical intervention in these women are high. Almost 30% of women in US will undergo hysterectomy by the age 60, with menorrhagia or DUB being the cause for surgery in 50-70% of these women. Endometrial ablation techniques have been FDA approved for women with abnormal uterine bleeding and with intramural fibroids less than 2 cm. The presence of submucosal uterine fibroids and a large uterus size have been shown to decrease the efficacy of standard endometrial ablation.
  • microwave ablation MAA
  • the known ablation treatments for Barrett esophagus include laser treatment ( Ertan et al, Am. J. Gastro., 90:2201-2203 [1995 ]), ultrasonic ablation ( Bremner et al, Gastro. Endo., 43:6 [1996 ]), photodynamic therapy (PDT) using photo-sensitizer drugs ( Overholt et al, Semin. Surq. Oncol., 1 :372-376 (1995 ), multipolar electrocoagulation such as by use of a bicap probe (Sampliner et al,), Argon Plasma Coagulation (APC; ), Radiofrequency ablation (Sharma et al. Gastrointest Endosc) and cryoablation (Johnston et al. Gastrointest Endosc).
  • the treatments are delivered with the aid of an endoscope and devices passed through the channel of endoscope or alongside the endoscope.
  • radiofrequency ablation uses a rigid bipolar balloon based electrode and radiofrequency thermal energy.
  • the thermal energy is delivered by direct contact of the electrode with the diseased Barrett epithelium allowing for a relatively uniform, large area ablation.
  • the rigid electrode does not accommodate for variations in esophageal size and is ineffective in ablating tortuous esophagus, proximal esophageal lesions as an esophagus narrows towards the top, and esophagus at the gastroesophagal junction due to changes in the esophagus diameter.
  • Nodular disease in Barrett esophagus also cannot be treated using the rigid bipolar RF electrode. Due to its size and rigidity, the electrode cannot be passed through the scope. In addition sticking of sloughed tissue to the electrode impedes with delivery of radiofrequency energy resulting in incomplete ablation.
  • the electrode size is limited to 3 cm, thus requiring repeat applications to treat larger lengths of Barrett esophagus.
  • Photodynamic therapy is a two part procedure that involves injecting a photo-sensitizer that is absorbed and retained by the neoplastic and pre-neoplastic tissue. The tissue is then exposed to a selected wavelength of light which activates the photo-sensitizer and results in tissue destruction. PDT is associated with complications such as stricture formation and photo-sensitivity which has limited its use to the most-advanced stages of the disease. In addition, patchy uptake of the photosensitizer results in incomplete ablation and residual neoplastic tissue.
  • Colon polyps are usually resected using snare resection with or without the use of monopolar cautery.
  • Flat polyps or residual polyps after snare resection have been treated with argon plasma coagulation or laser treatment. Both these treatments, have the previously mentioned limitations.
  • argon plasma coagulation or laser treatment Both these treatments, have the previously mentioned limitations.
  • most large flat polyps undergo surgical resection due to high risk of bleeding, perforation and residual disease using traditional endoscopic resection or ablation techniques.
  • balloon catheters traditionally used for tissue ablation either heat or cool the balloon itself or a heating element such as a radio frequency (RF) coils mounted on the balloon. This requires direct contact of the balloon catheter with the ablated surface.
  • RF radio frequency
  • the balloon catheter When the balloon catheter is deflated, the epithelium sticks to the catheter and sloughs off, thereby causing bleeding. Blood can interfere with delivery of energy i.e. energy sink.
  • reapplication of energy will result in deeper burn in the area where superficial lining has sloughed.
  • balloon catheters cannot be employed for treatment in non cylindrical organs, like the uterus or sinuses, and also do not provide non-circumferential or focal ablation in a hollow organ.
  • cryogens as ablative agents, which expand exponentially upon being heated, balloon catheters may result in a closed cavity and trap the escape of cryogen, resulting in complications such as perforations and tears.
  • ablation devices are disclosed, as e.g. a device to perform ablation of endometrial tissue, comprising a catheter having a shaft through which an ablative agent can travel, a first positioning element attached to said catheter shaft at a first position, wherein said first positioning element is configured to center said catheter in a center of a cervix, and a second positioning element attached to said catheter shaft at a second position, wherein the shaft comprises a plurality of ports through which said ablative agent can be released out of said shaft and wherein said ports are located between said first position and second position.
  • the first positioning element is conical.
  • the first positioning element comprises an insulated membrane which can be configured to prevent an escape of thermal energy through the cervix.
  • the second positioning element is disc shaped.
  • the second positioning element has a dimension which can be used to determine a uterine cavity size.
  • the second positioning element has a dimension which can be used to calculate an amount of thermal energy needed to ablate the endometrial tissue.
  • the device also includes at least one temperature sensor, which can be used to control delivery of the ablative agent, such as steam.
  • the second positioning element is separated from endometrial tissue to be ablated by a distance of greater than 0.1 mm.
  • the first positioning element is a covered wire mesh.
  • the first positioning element is comprises a circular body with a diameter between 0.1 mm and 10cm.
  • the second positioning element is oval and wherein said oval has a long axis between 0.1 mm and 10 cm and a short axis between 0.1 mm and 5 cm.
  • Another device to perform ablation of endometrial tissue comprises a catheter having a hollow shaft through which steam can be delivered, a first positioning element attached to said catheter shaft at a first position, wherein said first positioning element is conical and configured to center said catheter in a center of a cervix, a second positioning element attached to said catheter shaft at a second position, wherein the second positioning element is disc shaped, a plurality of ports integrally formed in said catheter shaft, wherein steam can be released out of said ports and directed toward endometrial tissue and wherein said ports are located between said first position and second position; and at least one temperature sensor.
  • the second positioning element has a dimension, which can be used to determine a uterine cavity size.
  • the second positioning element has a dimension, which can be used to calculate an amount of thermal energy needed to ablate the endometrial tissue.
  • the temperature sensors are used to control delivery of said ablative agent.
  • the first positioning element comprises wire mesh.
  • the second positioning element has a disc shape that is oval and wherein said oval has a long axis between 0.1mm and 10 cm and a short axis between 0.1 mm and 5 cm.
  • a device to perform ablation of tissue in a hollow organ comprising a catheter having a shaft through which an ablative agent can travel; a first positioning element attached to said catheter shaft at a first position, wherein said first positioning element is configured to position said catheter at a predefined distance from the tissue to be ablated; and wherein the shaft comprises one or more port through which said ablative agent can be released out of said shaft.
  • the device further comprises a second positioning element attached to said catheter shaft at a position different from said first positioning element.
  • the first positioning element is at least one of a conical shape, disc shape, or a free form shape conformed to the shape of the hollow organ.
  • the second positioning element has predefined dimensions and wherein said predefined dimensions are used to determine the dimensions of the hollow organ to be ablated.
  • the first positioning element comprises an insulated membrane.
  • the insulated membrane is configured to prevent an escape of thermal energy.
  • the second positioning element is at least one of a conical shape, disc shape, or a free form shape conformed to the shape of the hollow organ.
  • the second positioning element has predefined dimensions and wherein said predefined dimensions are used to determine the dimensions of the hollow organ to be ablated.
  • the second positioning element has a predefined dimension and wherein said predefined dimension is used to calculate an amount of thermal energy needed to ablate the tissue.
  • the device further comprises at least one temperature sensor.
  • the temperature sensor is used to control delivery of said ablative agent.
  • the ablative agent is steam.
  • the first positioning element is a covered wire mesh.
  • the first positioning element comprises a circular body with a diameter between 0.01 mm and 10cm.
  • the first positioning element is oval and wherein said oval has a long axis between 0.01 mm and 10 cm and a short axis between 0.01 mm and 9 cm.
  • Another device to perform ablation of tissue in a hollow organ comprises a catheter having a hollow shaft through which steam can be delivered; a first positioning element attached to said catheter shaft at a first position, wherein said first positioning element is configured to position said catheter at a predefined distance from the surface of the hollow organ; a second positioning element attached to said catheter shaft at a second position, wherein the second positioning element is shaped to position said catheter at a predefined distance from the surface of the hollow organ; a plurality of ports integrally formed in said catheter shaft, wherein steam can be released out of said ports and directed toward tissue to be ablated and wherein said ports are located between said first position and second position; and at least one temperature sensor.
  • the first positioning element has a predefined dimension and wherein said dimension is used to determine the size of the hollow organ.
  • the second positioning element has a predefined dimension and wherein said dimension is used to calculate an amount of thermal energy needed to ablate the tissue.
  • the temperature sensor is used to control delivery of said ablative agent.
  • the first positioning element comprises wire mesh.
  • the second positioning element has a disc shape that is oval and wherein said oval has a long axis between 0.01mm and 10 cm and a short axis between 0.01 mm and 9 cm.
  • Another device to perform ablation of the gastrointestinal tissue comprises a catheter having a shaft through which an ablative agent can travel; a first positioning element attached to said catheter shaft at a first position, wherein said first positioning element is configured to position the catheter at a fixed distance from the gastrointestinal tissue to be ablated, and wherein said first positioning element is separated from an ablation region by a distance of between 0 mm and 5 cm, and an input port at a second position and in fluid communication with said catheter shaft in order to receive said ablative agent wherein the shaft comprises one or more ports through which said ablative agent can be released out of said shaft.
  • the first positioning element is at least one of an inflatable balloon, wire mesh disc or cone.
  • the device creates an gastrointestinal pressure equal to or less than 5 atm.
  • the ablative agent has a temperature between -100 degrees Celsius and 200 degrees Celsius.
  • the catheter further comprises a temperature sensor.
  • the catheter further comprises a pressure sensor.
  • the first positioning element is configured to abut a gastroesophageal junction when placed in a gastric cardia.
  • the ports are located between said first position and second position.
  • the diameter of the positioning element is between 0.01 mm and 100 mm.
  • the ablative agent is steam.
  • the first positioning element comprises a circular body with a diameter between 0.01 mm and 10cm.
  • Another device to perform ablation of esophageal tissue comprises a catheter having a hollow shaft through which steam can be transported; a first positioning element attached to said catheter shaft at a first position, wherein said first positioning element is configured to abut a gastroesophageal junction when placed in a gastric cardia; and an input port at a second position and in fluid communication with said catheter shaft in order to receive said steam wherein the shaft comprises a plurality of ports through which said steam can be released out of said shaft and wherein said ports are located between said first position and second position.
  • the device further comprises a temperature sensor wherein said temperature sensor is used to control the release of said steam.
  • the first positioning element comprises at least one of a wire mesh disc, a wire mesh cone, or an inflatable balloon. The first positioning element is separated from an ablation region by a distance of between 0 mm and 1 cm. The diameter of the first positioning element is between 1 mm and 100 mm.
  • Another device to perform ablation of gastrointestinal tissue comprises a catheter having a hollow shaft through which steam can be transported; a first positioning element attached to said catheter shaft at a first position, wherein said first positioning element is configured to abut the gastrointestinal tissue; and an input port at a second position and in fluid communication with said catheter shaft in order to receive said steam wherein the shaft comprises one or more ports through which said steam can be released out of said shaft onto the gastrointestinal tissue.
  • the device further comprises a temperature sensor wherein said temperature sensor is used to control the release of said steam.
  • the first positioning element comprises at least one of a wire mesh disc and a wire mesh cone.
  • the diameter of the first positioning element is 0.1mm to 50mm.
  • the device is used to perform non-circumferential ablation.
  • Another device to perform ablation of endometrial tissue comprises a catheter having a shaft through which an ablative agent can travel; a first positioning element attached to said catheter shaft at a first position, wherein said first positioning element is configured to center said catheter in a center of a cervix; and a shaft comprises a plurality of ports through which said ablative agent can be released out of said shaft.
  • the device further comprises a second positioning element attached to said catheter shaft at a second position.
  • the first positioning element is conical.
  • the first positioning element comprises an insulated membrane.
  • the insulated membrane is configured to prevent an escape of thermal energy through the cervix.
  • the second positioning element is disc shaped.
  • the second positioning element has a predefined dimension and wherein said dimension is used to determine a uterine cavity size.
  • the second positioning element has a predefined dimension and wherein said dimension is used to calculate an amount of thermal energy needed to ablate the endometrial tissue.
  • the device further comprises at least one temperature sensor wherein said temperature sensor is used to control delivery of said ablative agent.
  • the ablative agent is steam.
  • the first positioning element is a covered wire mesh.
  • the first positioning element comprises a circular body with a diameter between 0.01 mm and 10cm.
  • the second positioning element is oval and wherein said oval has a long axis between 0.01 mm and 10 cm and a short axis between 0.01 mm and 5 cm.
  • Another device to perform ablation of endometrial tissue comprises a catheter having a hollow shaft through which steam can be delivered; a first positioning element attached to said catheter shaft at a first position, wherein said first positioning element is conical and configured to center said catheter in a center of a cervix; a second positioning element attached to said catheter shaft at a second position, wherein the second positioning element is elliptical shaped; a plurality of ports integrally formed in said catheter shaft, wherein steam can be released out of said ports and directed toward endometrial tissue and wherein said ports are located between said first position and second position; and at least one temperature sensor.
  • the second positioning element has a predefined dimension and wherein said dimension is used to determine a uterine cavity size.
  • the second positioning element has a diameter and wherein said diameter is used to calculate an amount of thermal energy needed to ablate the endometrial tissue.
  • the temperature sensors are used to control delivery of said ablative agent.
  • the first positioning element comprises wire mesh.
  • the second positioning element has a disc shape that is oval and wherein said oval has a long axis between 0.01mm and 10 cm and a short axis between 0.01 mm and 5 cm.
  • the second positioning element can use one or more sources of infrared, electromagnetic, acoustic or radiofrequency energy to measure the dimensions of the hollow cavity.
  • the energy is emitted from the sensor and is reflected back to the detector in the sensor.
  • the reflected data is used to determine the dimension of the hollow cavity.
  • the present invention provides an ablation device comprising a catheter with one or more centering or positioning attachments at one or more ends of the catheter to affix the catheter and its infusion port at a fixed distance from the ablative tissue which is not affected by the movements of the organ.
  • the arrangement of one or more spray ports allows for uniform spray of the ablative agent producing a uniform ablation of large area such as Barrett esophagus.
  • the flow of ablative agent is controlled by the microprocessor and depends upon one or more of the length or area of tissue to be ablated, type and depth of tissue to be ablated and distance of the infusion port from the tissue to be ablated.
  • Treatment refers to any reduction in the extent, frequency, or severity of one or more symptoms or signs associated with a condition.
  • Duration refers to the time course of a prescribed treatment, from initiation to conclusion, whether the treatment is concluded because the condition is resolved or the treatment is suspended for any reason. Over the duration of treatment, a plurality of treatment periods may be prescribed during which one or more prescribed stimuli are administered to the subject.
  • Period refers to the time over which a "dose" of stimulation is administered to a subject as part of the prescribe treatment plan.
  • the steps may be conducted in any feasible order. And, as appropriate, any combination of two or more steps may be conducted simultaneously.
  • Ablative agents such as steam, heated gas or cryogens such as but not limited to liquid nitrogen are inexpensive and readily available, and are directed via the infusion port onto the tissue, held at a fixed and consistent distance, targeted for ablation. This allows for uniform distribution of the ablative agent on the targeted tissue.
  • the flow of the ablative agent is controlled by a microprocessor according to a predetermined method based on the characteristic of the tissue to be ablated, required depth of ablation, and distance of the port from the tissue.
  • the microprocessor may use temperature, pressure or other sensing data to control the flow of the ablative agent.
  • one or more suction ports are provided to suction the ablation agent from the vicinity of the targeted tissue.
  • the targeted segment can be treated by a continuous infusion of the ablative agent or via cycles of infusion and removal of the ablative agent as determined and controlled by the microprocessor.
  • controller that comprises a microprocessor executing control instructions.
  • the controller can be in the form of any computing device, including desktop, laptop, and mobile device, and can communicate control signals to the ablation devices in wired or wireless form.
  • FIG. 1 illustrates an ablation device.
  • the ablation device comprises a catheter 10 having a distal centering or positioning attachment which is an inflatable balloon 11.
  • the catheter 10 is made of or covered with an insulated material to prevent the escape of ablative energy from the catheter body.
  • the ablation device comprises one or more infusion ports 12 for the infusion of ablative agent and one or more suction ports 13 for the removal of ablative agent.
  • the infusion port 12 and suction port 13 are the same.
  • Ablative agent is stored in a reservoir 14 connected to the catheter 10. Delivery of the ablative agent is controlled by a microprocessor 15 and initiation of the treatment is controlled by a treating physician using an input device, such as a foot-paddle 16.
  • the input device could be a voice recognition system (that is responsive to commands such as "start”, “more”, “less”, etc.), a mouse, a switch, footpad, or any other input device known to persons of ordinary skill in the art.
  • microprocessor 15 translates signals from the input device, such as pressure being placed on the foot-paddle or vocal commands to provide "more” or “less” ablative agent, into control signals that determine whether more or less ablative agent is dispensed.
  • Optional sensor 17 monitors changes in an ablative tissue or its vicinity to guide flow of ablative agent.
  • Optional infrared, electromagnetic, acoustic or radiofrequency energy emitter and sensor 18 measures the dimensions of the hollow organ.
  • the inflatable balloon has a diameter of between 1mm and 10cm. In one embodiment, the inflatable balloon is separated from the ports by a distance of 1mm to 10cm. In one embodiment, the size of the port openings are between 1 ⁇ m and 1 cm. It should be appreciated that the inflatable balloon is used to fix the device and therefore is configured to not contact the ablated area.
  • the inflatable balloon can be any shape that contacts the hollow organ at 3 or more points.
  • One of ordinary skill in the art that, using triangulation, one can calculate the distance of the catheter from the lesion. Alternatively the infrared, electromagnetic, acoustic or radiofrequency energy emitter and sensor 18 can measure the dimensions of the hollow organ.
  • the infrared, electromagnetic, acoustic or radiofrequency energy is emitted from the emitter 18 and is reflected back from the tissue to the detector in the emitter 18.
  • the reflected data can be used to determine the dimension of the hollow cavity. It should be appreciated that the emitter and sensor 18 can be incorporated into a single transceiver that is capable of both emitting energy and detecting the reflected energy.
  • Figure 2a illustrates a longitudinal section of the ablation device, depicting a distribution of infusion ports.
  • Figure 2b illustrates a cross section of a distribution of infusion ports on the ablation device.
  • the longitudinal and cross sectional view of the catheter 10 as illustrated in Figures 2a and 2b respectively, show one arrangement of the infusion ports 12 to produce a uniform distribution of ablative agent 21 in order to provide a circumferential area of ablation in a hollow organ 20.
  • Figure 2c illustrates a cross section of a distribution of infusion ports on the ablation device.
  • the arrangement of the infusion ports 12 as illustrated in Figure 2c produce a focal distribution of ablative agent 21 and a focal area of ablation in a hollow organ 20.
  • the size of the port, number of ports, and distance between the ports will be determined by the volume of ablative agent needed, pressure that the hollow organ can withstand, size of the hollow organ as measured by the distance of the surface from the port, length of the tissue to be ablated (which is roughly the surface area to be ablated), characteristics of the tissue to be ablated and depth of ablation needed.
  • FIG. 2d illustrates another embodiment of the ablation device.
  • the vapor ablation catheter comprises an insulated catheter 21 with one or more positioning attachments 22 of known length 23.
  • the vapor ablation catheter has one or more vapor infusion ports 25.
  • the length 24 of the vapor ablation catheter 21 with infusion ports 25 is determined by the length or area of the tissue to be ablated.
  • Vapor 29 is delivered through the vapor infusion ports 25.
  • the catheter 21 is preferably positioned in the center of the positioning attachment 22, and the infusion ports 25 are arranged circumferentially for circumferential ablation and delivery of vapor.
  • the catheter 21 can be positioned toward the periphery of the positioning attachment 22 and the infusion ports 25 can be arranged non-circumferentially, preferably linearly on one side for focal ablation and delivery of vapor.
  • the positioning attachment 23 is one of an inflatable balloon, a wire mesh disc with or without an insulated membrane covering the disc, a cone shaped attachment, a ring shaped attachment or a freeform attachment designed to fit the desired hollow body organ or hollow body passage, as further described below.
  • Optional infrared, electromagnetic, acoustic or radiofrequency energy emitter and sensor 28 are incorporated to measures the dimensions of the hollow organ.
  • the vapor ablation catheter may also comprise an optional coaxial sheet 27 to restrain the positioning attachment 22 in a manner comparable to a coronary metal stent.
  • the disc is made of memory metal or memory material with a compressed linear form and a non-compressed form in the shape of the positioning attachment.
  • the channel of an endoscope may perform the function of restraining the positioning attachment 22 by, for example, acting as a constraining sheath.
  • Optional sensor 26 is deployed on the catheter to measure changes associated with vapor delivery or ablation.
  • the sensor is one of temperature, pressure, photo or chemical sensor.
  • one or more, infrared, electromagnetic, acoustic or radiofrequency energy emitter and sensor 28 can measure the dimensions of the hollow organ.
  • the infrared, electromagnetic, acoustic or radiofrequency energy is emitted from the emitter 18 and is reflected back from the tissue to the detector in the emitter 18.
  • the reflected data can be used to determine the dimension of the hollow cavity.
  • the measurement is performed at one or multiple points to get an accurate estimate of the dimension of the hollow organ.
  • the data can also be used to create a topographic representation of the hollow organ.
  • Figure 3a illustrates the ablation device placed in an upper gastrointestinal tract with Barrett esophagus to selectively ablate the Barrett tissue.
  • the upper gastrointestinal tract comprises Barrett esophagus 31, gastric cardia 32, gastroesophageal junction 33 and displaced squamo-columnar junction 34.
  • the area between gastroesophageal junction 33 and displaced squamo-columnar junction 34 is Barrett esophagus 31, which is targeted for ablation.
  • Distal to the cardia 32 is the stomach 35 and proximal to the cardia 32 is the esophagus 36.
  • the ablation device is passed into the esophagus 36 and the positioning device 11 is placed in the gastric cardia 32 abutting the gastroesophageal junction 33.
  • This affixes the ablation catheter 10 and its ports 12 in the center of the esophagus 36 and allows for uniform delivery of the ablative agent 21 to the Barrett esophagus 31.
  • the positioning device is first affixed to an anatomical structure, not being subjected to ablation, before ablation occurs. Where the patient is undergoing circumferential ablation or first time ablation, the positioning attachment is preferably placed in the gastric cardia, abutting the gastroesophageal junction.
  • the positioning attachment must be separated from the ablation region by a distance of greater than 0 mm, preferably 1 mm and ideally 1 cm.
  • the size of the positioning device is in the range of 10 to 100 mm, preferably 20-40 mm, although one of ordinary skill in the art would appreciate that the precise dimensions are dependent on the size of the patient's esophagus.
  • the delivery of ablative agent 21 through the infusion port 12 is controlled by the microprocessor 15 coupled with the ablation device.
  • the delivery of ablative agent is guided by predetermined programmatic instructions, depending on the tissue to be ablated and the depth of ablation required.
  • the target procedural temperature will need to be between -100 degrees Celsius and 200 degrees Celsius, preferably between 50 degrees Celsius and 75 degrees Celsius, as further shown in the dosimetery table below.
  • esophageal pressure should not to exceed 5 atm, and is preferably below 0.5atm.
  • the target procedural temperature is achieved in less than 1 minute, preferably in less than 5 seconds, and is capable of being maintained for up to 10 minutes, preferably 1 to 10 seconds, and then cooled to body temperature.
  • the treatment can be repeated until the desired ablation effect is achieved.
  • Optional sensor 17 monitors intraluminal parameters such as temperature and pressure and can increase or decrease the flow of ablative agent 21 through the infusion port 12 to obtain adequate heating or cooling, resulting in adequate ablation.
  • the sensor 17 monitors intraluminal parameters such as temperature and pressure and can increase or decrease the removal of ablative agent 21 through the optional suction port 13 to obtain adequate heating or cooling resulting in adequate ablation of Barrett esophagus 31.
  • Figure 3b illustrates the ablation device placed in an upper gastrointestinal tract with Barrett esophagus to selectively ablate the Barrett tissue. As illustrated in FIG. 3b , the positioning device 11 is a wire mesh disc.
  • the positioning attachment must be separated from the ablation region by a distance of greater than 0 mm, preferably 1 mm and ideally 1 cm. In one embodiment, the positioning attachment is removably affixed to the cardia or EG junction (for the distal attachment) or in the esophagus by a distance of greater than 0.1 mm, preferably around 1 cm, above the proximal most extent of the Barrett tissue (for the proximal attachment).
  • FIG. 3b is another embodiment of the Barrett ablation device where the positioning element 11 is a wire mesh disc.
  • the wire mesh may have optional insulated membrane to prevent the escape of the ablative agent.
  • two wire mesh discs are used to center the ablation catheter in the esophagus. The distance between the two discs is determined by the length of the tissue to ablated which, in this case, would be the length of the Barrett esophagus.
  • Optional infrared, electromagnetic, acoustic or radiofrequency energy emitter and sensor 18 are incorporated to measures the diameter of the esophagus.
  • FIG. 3c is a flowchart illustrating the basic procedural steps for using the ablation device.
  • a catheter of the ablation device is inserted into a hollow organ which is to be ablated.
  • the catheter is inserted into the Barrett esophagus via the esophagus of the patient.
  • a positioning element of the ablation device is deployed.
  • the balloon is inflated in order to position the ablation device at a known fixed distance from the tissue to be ablated.
  • the diameter of the hollow organ may either be predetermined by using radiological tests such as barium X-rays or computer tomography (CT) scan, or by using pressure volume cycle, i.e by determining volume needed to raise pressure to a fixed level (say 1 atm) in a fixed volume balloon.
  • CT computer tomography
  • pressure volume cycle i.e by determining volume needed to raise pressure to a fixed level (say 1 atm) in a fixed volume balloon.
  • the positioning device is disc shaped, circumferential rings are provided in order to visually communicate to an operating physician the diameter of the hollow organ.
  • the positioning device enables centering of the catheter of the ablation device in a non-cylindrical body cavity, and the volume of the cavity is measured by the length of catheter or a uterine sound.
  • one or more, infrared, electromagnetic, acoustic or radiofrequency energy emitter and sensor can be used to measure the dimensions of the hollow organ.
  • the infrared, electromagnetic, acoustic or radiofrequency energy is emitted from the emitter and is reflected back from the tissue to a detector in the emitter.
  • the reflected data can be used to determine the dimension of the hollow cavity.
  • the measurement can be performed at one or multiple points to get an accurate estimate of the dimension of the hollow organ.
  • the data from multiple points can also be used to create a topographic representation of the hollow organ or to calculate the volume of the hollow organ.
  • the positioning attachment must be separated from the ports by a distance of 0 mm or greater, preferably greater than 0.1 mm, and more preferably 1 cm.
  • the size of the positioning device depends on the hollow organ being ablated and ranges from 1 mm to 10 cm.
  • the diameter of the positioning element is between 0.01 mm and 100 mm.
  • the first positioning element comprises a circular body with a diameter between 0.01 mm and 10 cm.
  • the organ is ablated by automated delivery of an ablative agent such as steam via infusion ports provided on the catheter.
  • the delivery of the ablative agent through the infusion ports is controlled by a microprocessor coupled with the ablation device.
  • the delivery of ablative agent is guided by predetermined programmatic instructions depending on the tissue to be ablated and the depth of ablation required.
  • the dose of the ablative agent is determined by conducting dosimetery study to determine the dose to ablate endometrial tissue.
  • the variable that enables determination of total dose of ablative agent is the volume (or mass) of the tissue to be treated which is calculated by using the length of the catheter and diameter of the organ (for cylindrical organs).
  • the determined dose of ablative agent is then delivered using micro-processor controlled steam generator.
  • the dose is provided by first determining what the disorder being treated is and what the desired tissue effect is, and then finding the corresponding temperature, as shown in the tables below.
  • Temp Tissue Effect 37-40 No significant tissue effect 41-44 Reversible cell damage in few hours 45-49 Irreversible cell damage at shorter intervals 50-69 Irreversible cell damage -ablation necrosis at shorter intervals 70 Threshold temp for tissue shrinkage, H-bond breakage 70-99 Coagulation and Hemostasis 100-200 Desiccation and Carbonization of tissue > 200 Charring of tissue glucose Disorder Max.
  • the depth of ablation desired determines the holding time at the maximum temperature.
  • the holding time at the maximum temperature is very short (flash burn) and does not allow for heat to transfer to the deeper layers. This will prevent damage to deeper normal tissue and hence prevention patient discomfort and complication.
  • the holding time at the maximum temperature will be longer, thereby allowing the heat to percolate deeper.
  • Figure 4a illustrates the ablation device placed in a colon to ablate a flat colon polyp.
  • the ablation catheter 10 is passed through a colonoscope 40.
  • the positioning device 11 is placed proximal to a flat colonic polyp 41 which is to be ablated, in the normal colon 42.
  • the positioning device 11 is one of an inflatable balloon, a wire mesh disc with or without an insulated membrane covering the disc, a cone shaped attachment, a ring shaped attachment or a freeform attachment designed to fit the colonic lumen.
  • the positioning device 11 has the catheter 10 located toward the periphery of the positioning device 11 placing it closer to the polyp 41 targeted for non-circumferential ablation.
  • the positioning device 11 fixes the catheter to the colon 42 at a predetermined distance from the polyp 41 for uniform and focused delivery of the ablative agent 21.
  • the delivery of ablative agent 21 through the infusion port 12 is controlled by the microprocessor 15 attached to the ablation device and depends on tissue and the depth of ablation required.
  • the delivery of ablative agent 21 is guided by predetermined programmatic instructions depending on the tissue to be ablated and the area and depth of ablation required.
  • the ablation device allows for focal ablation of diseased polyp mucosa without damaging the normal colonic mucosa located away from the catheter ports.
  • the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, ideally more than 5 mm.
  • the positioning element is proximal to the colon polyp. For this application, the embodiment shown in Figure 4b would be preferred.
  • Figure 4b illustrates the ablation device placed in a colon to ablate a flat colon polyp.
  • the positioning device is a conical attachment at the tip of the catheter.
  • the conical attachment has a known length '1' and diameter 'd' that is used to calculate the amount of thermal energy needed to ablate the flat colon polyp.
  • the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm.
  • the length '1' is greater than 0.1 mm, preferably between 5 and 10 mm.
  • diameter 'd' depends on the size of the polyp and can be between 1 mm and 10 cm, preferably 1 to 5 cm. This embodiment can also be used to ablate residual neoplastic tissue at the edges after endoscopic snare resection of a large sessile colon polyp.
  • Figure 5a illustrates the ablation device with a coaxial catheter design, in accordance with an embodiment of the present invention.
  • the coaxial design has a handle 52a, an infusion port 53a, an inner sheath 54a and an outer sheath 55a.
  • the outer sheath 55a is used to constrain the positioning device 56a in the closed position and encompasses ports 57a.
  • Figure 5b shows a partially deployed positioning device 56b, with the ports 57b still within the outer sheath 55b.
  • the positioning device 56b is partially deployed by pushing the catheter 54b out of sheath 55b.
  • Figure 5c shows a completely deployed positioning device 56c.
  • the infusion ports 57c are out of the sheath 55c.
  • the length '1' of the catheter 54c that contains the infusion port 57c and the diameter 'd' of the positioning element 56c are predetermined / known and are used to calculate the amount of thermal energy needed.
  • Figure 5d illustrates a conical design of the positioning element.
  • the positioning element 56d is conical with a known length '1' and diameter 'd' that is used to calculate the amount of thermal energy needed for ablation.
  • Figure 5e illustrates a disc shaped design of the positioning element 56e comprising circumferential rings 59e.
  • the circumferential rings 59e are provided at a fixed predetermined distance and are used to estimate the diameter of a hollow organ or hollow passage in a patient's body.
  • FIG. 6 illustrates an upper gastrointestinal tract with a bleeding vascular lesion being treated by the ablation device.
  • the vascular lesion is a visible vessel 61 in the base of an ulcer 62.
  • the ablation catheter 63 is passed though the channel of an endoscope 64.
  • the conical positioning element 65 is placed over the visible vessel 61.
  • the conical positioning element 65 has a known length '1' and diameter 'd', which are used to calculate the amount of thermal energy needed for coagulation of the visible vessel to achieve hemostasis.
  • the conical positioning element has an optional insulated membrane that prevents escape of thermal energy or vapor away from the disease site.
  • the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm.
  • the length '1' is greater than 0.1 mm, preferably between 5 and 10 mm.
  • diameter 'd' depends on the size of the lesion and can be between 1 mm and 10 cm, preferably 1 to 5 cm.
  • Figure 7 illustrates endometrial ablation being performed in a female uterus by using the ablation device.
  • a cross-section of the female genital tract comprising a vagina 70, a cervix 71, a uterus 72, an endometrium 73, fallopian tubes 74, ovaries 75 and the fundus of the uterus 76 is illustrated.
  • a catheter 77 of the ablation device is inserted into the uterus 72 through the cervix 71.
  • the catheter 77 has two positioning elements, a conical positioning element 78 and a disc shaped positioning element 79.
  • the positioning element 78 is conical with an insulated membrane covering the conical positioning element 78.
  • the conical element 78 positions the catheter 77 in the center of the cervix 71 and the insulated membrane prevents the escape of thermal energy or ablative agent through the cervix 71.
  • the second disc shaped positioning element 79 is deployed close to the fundus of the uterus 76 positioning the catheter 71 in the middle of the cavity.
  • An ablative agent 778 is passed through infusion ports 777 for uniform delivery of the ablative agent 778 into the uterine cavity.
  • Predetermined length "1" of the ablative segment of the catheter and diameter 'd' of the positioning element 79 allows for estimation of the cavity size and is used to calculate the amount of thermal energy needed to ablate the endometrial lining.
  • Optional temperature sensors 7 deployed close to the endometrial surface are used to control the delivery of the ablative agent 778.
  • Optional topographic mapping using multiple infrared, electromagnetic, acoustic or radiofrequency energy emitter and sensor can be used to define cavity size and shape in patients with irregular or deformed uterine cavity due to conditions such as fibroids.
  • the ablative agent is steam which contracts on cooling. Steam turns to water which has a lower volume as compared to a cryogen that will expand or a hot fluid used in hydrothermal ablation whose volume stays constant. With both cryogens and hot fluids, increasing energy delivery is associated with increasing volume of the ablative agent which, in turn, requires mechanisms for removing the agent, otherwise the medical provider will run into complications. However, steam, on cooling, turn into water which occupies significantly less volume; therefore, increasing energy delivery is not associated with an increase in volume of the residual ablative agent, thereby eliminating the need for continued removal. This further decreases the risk of leakage of the thermal energy via the fallopian tubes 74 or the cervix 71, thus reducing any risk of thermal injury to adjacent healthy tissue.
  • the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm. In another embodiment, the positioning attachment can be in the ablated region as long as it does not cover a significant surface area. For endometrial ablation, 100% of the tissue does not need to be ablated to achieve the desired therapeutic effect.
  • the preferred distal positioning attachment is an uncovered wire mesh that is positioned proximate to the mid body region.
  • the preferred proximal positioning device is a covered wire mesh that is pulled into the cervix, centers the device, and occludes the cervix.
  • One or more such positioning devices may be helpful to compensate for the anatomical variations in the uterus.
  • the proximal positioning device is preferably oval, with a long axis being between 0.1mm and 10cm (preferably 1cm to 5cm) and a short axis between 0.1mm and 5cm (preferably 0.5cm to 1cm).
  • the distal positioning device is preferably circular with a diameter between 0.1 mm and 10cm, preferably 1cm to 5cm.
  • Figure 8 illustrates sinus ablation being performed in a nasal passage by using the ablation device.
  • a cross-section of the nasal passage and sinuses comprising nares 81, nasal paasages 82, frontal sinus 83, ethemoid sinus 84, and diseased sinus epithelim 85 is illustrated.
  • the catheter 86 is inserted into the frontal sinus 83 or the ethemoid sinus 84 through the nares 81 and nasal passages 82.
  • the catheter 86 has two positioning elements, a conical positioning element 87 and a disc shaped positioning element 88.
  • the positioning element 87 is conical and has an insulated membrane covering.
  • the conical element 87 positions the catheter 86 in the center of the sinus opening 80 and the insulated membrane prevents the escape of thermal energy or ablative agent through the opening.
  • the second disc shaped positioning element 88 is deployed in the frontal sinus cavity 83 or ethemoid sinus cavity 84, positioning the catheter 86 in the middle of either sinus cavity.
  • the ablative agent 8 is passed through the infusion port 89 for uniform delivery of the ablative agent 8 into the sinus cavity.
  • the predetermined length "1" of the ablative segment of the catheter and diameter 'd' of the positioning element 88 allows for estimation of the sinus cavity size and is used to calculate the amount of thermal energy needed to ablate the diseased sinus epithelium 85.
  • Optional temperature sensors 888 are deployed close to the diseased sinus epithelium 85 to control the delivery of the ablative agent 8.
  • the ablative agent 8 is steam which contracts on cooling. This further decreases the risk of leakage of the thermal energy thus reducing any risk of thermal injury to adjacent healthy tissue.
  • the dimensional ranges of the positioning elements are similar to those in the endometrial application, with preferred maximum ranges being half thereof.
  • Optional topographic mapping using multiple infrared, electromagnetic, acoustic or radiofrequency energy emitter and sensor can be used to define cavity size and shape in patients with irregular or deformed nasal cavity due to conditions such as nasal polyps.
  • Figure 9 illustrates bronchial and bullous ablation being performed in a pulmonary system by using the ablation device.
  • a cross-section of the pulmonary system comprising bronchus 91, normal alveolus 92, bullous lesion 93, and a bronchial neoplasm 94 is illustrated.
  • the catheter 96 is inserted through the channel of a bronchoscope 95 into the bronchus 91 and advanced into a bullous lesion 93.
  • the catheter 96 has two positioning elements, a conical positioning element 97 and a disc shaped positioning element 98.
  • the positioning element 97 is conical having an insulated membrane covering.
  • the conical element 97 positions the catheter 96 in the center of the bronchus 91 and the insulated membrane prevents the escape of thermal energy or ablative agent through the opening into the normal bronchus.
  • the second disc shaped positioning element 98 is deployed in the bullous cavity 93 positioning the catheter 96 in the middle of the bullous cavity 93.
  • An ablative agent 9 is passed through the infusion port 99 for uniform delivery into the sinus cavity.
  • Predetermined length "1" of the ablative segment of the catheter 96 and diameter 'd' of the positioning element 98 allow for estimation of the bullous cavity size and is used to calculate the amount of thermal energy needed to ablate the diseased bullous cavity 93.
  • the size of the cavity can be calculated from radiological evaluation using a chest CAT scan or MRI.
  • Optional temperature sensors are deployed close to the surface of the bullous cavity 93 to control the delivery of the ablative agent 9.
  • the ablative agent is steam which contracts on cooling. This further decreases the risk of leakage of the thermal energy into the normal bronchus thus reducing any risk of thermal injury to adjacent normal tissue.
  • the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm. In another embodiment, the positioning attachment can be in the ablated region as long as it does not cover a significant surface area.
  • the endoscope is used as one fixation point with one positioning element.
  • the positioning device is between 0.1mm and 5cm (preferably 1 mm to 2 cm).
  • the distal positioning device is preferably circular with a diameter between 0.1 mm and 10cm, preferably 1cm to 5cm.
  • the catheter 96 is inserted through the channel of a bronchoscope 95 into the bronchus 91 and advanced across the bronchial neoplasm 94.
  • the positioning element 98 is disc shaped having an insulated membrane covering. The positioning element 98 positions the catheter in the center of the bronchus 91 and the insulated membrane prevents the escape of thermal energy or ablative agent through the opening into the normal bronchus.
  • the ablative agent 9 is passed through the infusion port 99 in a non-circumferential pattern for uniform delivery of the ablative agent to the bronchial neoplasm 94.
  • the predetermined length "1" of the ablative segment of the catheter and diameter 'd' of the positioning element 98 are used to calculate the amount of thermal energy needed to ablate the bronchial neoplasm 94.
  • Figure 10 illustrates prostate ablation being performed on an enlarged prostrate in a male urinary system by using the device.
  • a cross-section of a male genitourinary tract having an enlarged prostate 101, bladder 102, and urethra 103 is illustrated.
  • the urethra 103 is compressed by the enlarged prostate 101.
  • the ablation catheter 105 is passed through the cystoscope 104 positioned in the urethra 103 distal to the obstruction.
  • the positioning elements 106 are deployed to center the catheter in the urethra 103 and insulated needles 107 are passed to pierce the prostate 101.
  • the vapor ablative agent 108 is passed through the insulated needles 107 thus causing ablation of the diseased prostatic tissue resulting in shrinkage of the prostate.
  • the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm to 5 mm and no more than 2 cm. In another embodiment, the positioning attachment can be deployed in the bladder and pulled back into the urethral opening /neck of the bladder thus fixing the catheter. In one embodiment, the positioning device is between 0.1mm and 10 cm.
  • FIG 11 illustrates fibroid ablation being performed in a female uterus by using the ablation device.
  • a cross-section of a female genitourinary tract comprising a uterine fibroid 111, uterus 112, and cervix 113 is illustrated.
  • the ablation catheter 115 is passed through the hysteroscope 114 positioned in the uterus distal to the fibroid 111.
  • the ablation catheter 115 has a puncturing tip 120 that helps puncture into the fibroid 111.
  • the positioning elements 116 are deployed to center the catheter in the fibroid and insulated needles 117 are passed to pierce the fibroid tissue 111.
  • the vapor ablative agent 118 is passed through the needles 117 thus causing ablation of the uterine fibroid 111 resulting in shrinkage of the fibroid.
  • FIG 12 illustrates a vapor delivery system using an RF heater for supplying vapor to the ablation device.
  • the vapor is used as an ablative agent in conjunction with the ablation device described in the present invention.
  • RF heater 64 is located proximate a pressure vessel 42 containing a liquid 44.
  • RF heater 64 heats vessel 42, in turn heating the liquid 44.
  • the liquid 44 heats up and begins to evaporate causing an increase in pressure inside the vessel 42.
  • the pressure inside vessel 42 can be kept fairly constant by providing a thermal switch 46 that controls resistive heater 64. Once, the temperature of the liquid 44 reaches a predetermined temperature, the thermal switch 46 shuts off RF heater 64.
  • the vapor created in pressure vessel 42 may be released via a control valve 50.
  • the target temperature of vessel 42 may be set to approximately 108°C, providing a continuous supply of vapor. As the vapor is released, it undergoes a pressure drop, which reduces the temperature of the vapor to a range of approximately 90-100° C. As liquid 44 in vessel 42 evaporates and the vapor exits vessel 42, the amount of liquid 44 slowly diminishes.
  • the vessel 42 is optionally connected to reservoir 43 containing liquid 44 via a pump 49 which can be turned on by the controller 24 upon sensing a fall in pressure or temperature in vessel 42 delivering additional liquid 44 to the vessel 42.
  • Vapor delivery catheter 16 is connected to vessel 42 via a fluid connector 56.
  • control valve 50 When control valve 50 is open, vessel 42 is in fluid communication with delivery catheter 16 via connector 56.
  • Control switch 60 may serve to turn vapor delivery on and off via actuator 48.
  • control switch 60 may physically open and close the valve 50, via actuator 48, to control delivery of vapor stream from the vessel 42.
  • Switch 60 may be configured to control other attributes of the vapor such as direction, flow, pressure, volume, spray diameter, or other parameters.
  • switch 60 may electrically communicate with a controller 24.
  • Controller 24 controls the RF heater 64, which in turn controls attributes of the vapor, in response to actuation of switch 60 by the operator.
  • controller 24 may control valves temperature or pressure regulators associated with catheter 16 or vessel 42.
  • a flow meter 52 may be used to measure the flow, pressure, or volume of vapor delivery via the catheter 16.
  • the controller 24 controls the temperature and pressure in the vessel 42 and the time, rate, flow, volume of vapor flow through the control valve 50. These parameters are set by the operator 11.
  • the pressure created in vessel 42, using the target temperature of 108° c. may be in the order of 25 pounds per square inch (psi) (1.72 bars).
  • FIG. 13 illustrates a vapor delivery system using a resistive heater for supplying vapor to the ablation device.
  • the generated vapor is used as an ablative agent in conjunction with the ablation device described in the present invention.
  • Resistive heater 40 is located proximate a pressure vessel 42.
  • Vessel 42 contains a liquid 44.
  • Resistive heater 40 heats vessel 42, in turn heating liquid 44. Accordingly, liquid 44 heats and begins to evaporate.
  • the vapor inside vessel 42 causes an increase in pressure in the vessel.
  • the pressure in vessel 42 can be kept fairly constant by providing a thermal switch 46 that controls resistive heater 40. When the temperature of liquid 44 reaches a predetermined temperature, thermal switch 46 shuts off resistive heater 40.
  • the vapor created in pressure vessel 42 may be released via a control valve 50. As the vapor exits vessel 42, vessel 42 experiences a pressure drop. The pressure drop of vessel 42 results in a reduction of temperature. The reduction of temperature is measured by thermal switch 46, and resistive heater 40 is turned back on to heat liquid 44.
  • the target temperature of vessel 42 may be set to approximately 108°C, providing a continuous supply of vapor. As the vapor is released, it undergoes a pressure drop, which reduces the temperature of the vapor to a range of approximately 90-100° C. As liquid 44 in vessel 42 evaporates and the vapor exits vessel 42, the amount of liquid 44 slowly diminishes.
  • the vessel 42 is connected to another vessel 43 containing liquid 44 via a pump 49 which can be turned on by the controller 24 upon sensing a fall in pressure or temperature in vessel 44 delivering additional liquid 44 to the vessel 42.
  • Vapor delivery catheter 16 is connected to vessel 42 via a fluid connector 56.
  • control valve 50 When control valve 50 is open, vessel 42 is in fluid communication with delivery catheter 16 via connector 56.
  • Control switch 60 may serve to turn vapor delivery on and off via actuator 48.
  • control switch 60 may physically open and close the valve 50, via actuator 48, to control delivery of vapor stream from the vessel 42.
  • Switch 60 may be configured to control other attributes of the vapor such as direction, flow, pressure, volume, spray diameter, or other parameters.
  • switch 60 may electrically communicate with a controller 24. Controller 24 controls the resistive heater 40, which in turn controls attributes of the vapor, in response to actuation of switch 60 by the operator.
  • controller 24 may control valves temperature or pressure regulators associated with catheter 16 or vessel 42.
  • a flow meter 52 may be used to measure the flow, pressure, or volume of vapor delivery via the catheter 16.
  • the controller 24 controls the temperature and pressure in the vessel 42 as well as time, rate, flow, volume of vapor flow through the control valve 50. These parameters are set by the operator 11.
  • the pressure created in vessel 42, using the target temperature of 108°C, may be on the order of 25 pounds per square inch (psi) (1.72 bars).
  • the device of the present invention can be used to cause controlled focal or circumferential ablation of targeted tissue to varying depth in a manner in which complete healing with re-epithelialization can occur.
  • the dose and manner of treatment can be adjusted based on the type of tissue and the depth of ablation needed.
  • the ablation device can be used not only for the treatment of Barrett esophagus and esophageal dysplasia, flat colon polyps, gastrointestinal bleeding lesions, endometrial ablation, pulmonary ablation, but also for the treatment of any mucosal, submucosal or circumferential lesion, such as inflammatory lesions, tumors, polyps and vascular lesions.
  • the ablation device can also be used for the treatment of focal or circumferential mucosal or submucosal lesion of any hollow organ or hollow body passage in the body.
  • the hollow organ can be one of gastrointestinal tract, pancreaticobiliary tract, genitourinary tract, respiratory tract or a vascular structure such as blood vessels.
  • the ablation device can be placed endoscopically, radiologically, surgically or under direct visualization.
  • wireless endoscopes or single fiber endoscopes can be incorporated as a part of the device.

Claims (11)

  1. Un dispositif pour effectuer une ablation de tissu dans un organe creux, comprenant
    a. un cathéter présentant un conduit (54a, 54b, 54c) dans lequel peut cheminer un agent ablatif ;
    b. un premier élément de positionnement (56a, 56b, 56c, 56e) attaché audit conduit de cathéter (54a, 54b, 54c) à une première position,
    dans lequel ledit premier élément de positionnement (56a, 56b, 56c, 56e) est configuré pour positionner ledit cathéter à une distance prédéfinie du tissu devant être ablaté ; et
    c. dans lequel le conduit comprend un ou plusieurs orifices (57a, 57b, 57c) par lesquels ledit agent ablatif peut être évacué dudit conduit (54a, 54b, 54c),
    caractérisé en ce que la circulation de l'agent ablatif est commandée par un microprocesseur qui utilise une longueur du cathéter et un diamètre du premier élément de positionnement (56a, 56b, 56c, 56e) pour calculer une quantité d'énergie thermique nécessaire pour l'ablation du tissu.
  2. Le dispositif de la revendication 1 comprenant en sus une poignée (52a).
  3. Le dispositif de la revendication 1 dans lequel le premier élément de positionnement (56a, 56b, 56c, 56e) a au moins une forme parmi une forme conique ou une forme en disque.
  4. Le dispositif de la revendication 1 dans lequel ledit cathéter a une conception coaxiale avec une gaine interne (54a, 54b, 54c) et une gaine externe (55a, 55b, 55c).
  5. Le dispositif de la revendication 4 dans lequel lesdits un ou plusieurs orifices (57a, 57b, 57c) sont positionnés sur ladite gaine interne (54a, 54b, 54c).
  6. Le dispositif de la revendication 5 dans lequel ledit élément de positionnement (56a, 56b, 56c, 56e) peut être déployé entre une position fermée dans laquelle ladite gaine externe (55a, 55b, 55c) restreint ledit élément de positionnement (56a, 56b, 56c, 56e) et une position déployée dans laquelle ladite gaine interne (54a, 54b, 54c) est poussée hors de ladite gaine externe (55a, 55b, 55c) pour déployer ledit élément de positionnement (56a, 56b, 56c, 56e).
  7. Le dispositif de la revendication 6 dans lequel, lorsque ledit élément de positionnement (56a, 56b, 56c, 56e) est dans ladite position fermée, lesdits orifices (57a, 57b, 57c) sont encadrés par et au sein de ladite gaine externe (55a, 55b, 55c).
  8. Le dispositif de la revendication 1 comprenant un élément de positionnement de forme conique (56a, 56b) ayant une longueur et un diamètre connus qui sont utilisés pour calculer une quantité d'énergie thermique nécessaire pour l'ablation.
  9. Le dispositif de la revendication 1 comprenant un élément de positionnement formé comme un disque (56e) ayant des anneaux circonférentiels prévus à une distance prédéterminée fixe et utilisés pour estimer un diamètre d'un organe creux ou passage creux dans le corps d'un patient.
  10. Le dispositif de la revendication 1 comprenant en sus un orifice d'infusion (53a).
  11. Le dispositif de n'importe lesquelles des revendications 1 à 10 dans lequel le diamètre du premier élément de positionnement (56a, 56b, 56c, 56e) est utilisé pour déterminer le diamètre de l'organe creux.
EP09819726.2A 2008-10-06 2009-10-06 Appareil d'ablation de tissus Active EP2341859B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP16205336.7A EP3175805A1 (fr) 2008-10-06 2009-10-06 Appareil d'ablation de tissus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10288508P 2008-10-06 2008-10-06
PCT/US2009/059609 WO2010042461A1 (fr) 2008-10-06 2009-10-06 Procédé et appareil d'ablation de tissus

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP16205336.7A Division EP3175805A1 (fr) 2008-10-06 2009-10-06 Appareil d'ablation de tissus
EP16205336.7A Division-Into EP3175805A1 (fr) 2008-10-06 2009-10-06 Appareil d'ablation de tissus

Publications (3)

Publication Number Publication Date
EP2341859A1 EP2341859A1 (fr) 2011-07-13
EP2341859A4 EP2341859A4 (fr) 2013-01-16
EP2341859B1 true EP2341859B1 (fr) 2017-04-05

Family

ID=42099552

Family Applications (2)

Application Number Title Priority Date Filing Date
EP09819726.2A Active EP2341859B1 (fr) 2008-10-06 2009-10-06 Appareil d'ablation de tissus
EP16205336.7A Ceased EP3175805A1 (fr) 2008-10-06 2009-10-06 Appareil d'ablation de tissus

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP16205336.7A Ceased EP3175805A1 (fr) 2008-10-06 2009-10-06 Appareil d'ablation de tissus

Country Status (4)

Country Link
US (6) US9700365B2 (fr)
EP (2) EP2341859B1 (fr)
CN (2) CN102238920B (fr)
WO (1) WO2010042461A1 (fr)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7892229B2 (en) 2003-01-18 2011-02-22 Tsunami Medtech, Llc Medical instruments and techniques for treating pulmonary disorders
US8016823B2 (en) 2003-01-18 2011-09-13 Tsunami Medtech, Llc Medical instrument and method of use
US9433457B2 (en) 2000-12-09 2016-09-06 Tsunami Medtech, Llc Medical instruments and techniques for thermally-mediated therapies
US7455666B2 (en) 2001-07-13 2008-11-25 Board Of Regents, The University Of Texas System Methods and apparatuses for navigating the subarachnoid space
US20110077628A1 (en) * 2006-01-10 2011-03-31 Tsunami Medtech, Llc Medical system and method of use
WO2009009398A1 (fr) 2007-07-06 2009-01-15 Tsunami Medtech, Llc Système médical et procédé d'utilisation
US8322335B2 (en) 2007-10-22 2012-12-04 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
US9924992B2 (en) 2008-02-20 2018-03-27 Tsunami Medtech, Llc Medical system and method of use
DE102008011811B3 (de) * 2008-02-29 2009-10-15 Anton Dr. Kasenbacher Dentales Laserbearbeitungsgerät zur Bearbeitung von Zahnmaterial
BRPI0908909A2 (pt) * 2008-03-21 2019-09-24 Uptake Medical Corp método e sistema de determinação de parâmetros de tratamento para a aplicação de energia ao tecido pulmonar com vapor
US8721632B2 (en) * 2008-09-09 2014-05-13 Tsunami Medtech, Llc Methods for delivering energy into a target tissue of a body
DE102008047640B4 (de) * 2008-09-17 2012-10-25 Anton Kasenbacher Verwendung eines Laserbearbeitungsgeräts zur Ablation von Zahnmaterial
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US10064697B2 (en) 2008-10-06 2018-09-04 Santa Anna Tech Llc Vapor based ablation system for treating various indications
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US9561066B2 (en) * 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
EP2341859B1 (fr) 2008-10-06 2017-04-05 Virender K. Sharma Appareil d'ablation de tissus
US10603489B2 (en) 2008-10-09 2020-03-31 Virender K. Sharma Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage
WO2010042686A1 (fr) 2008-10-09 2010-04-15 Sharma Virender K Procédé et appareil pour stimuler le système vasculaire
WO2010054237A1 (fr) 2008-11-06 2010-05-14 Nxthera, Inc. Systèmes et méthodes de traitement de la bph
JP2012508067A (ja) 2008-11-06 2012-04-05 エヌエックスセラ インコーポレイテッド 前立腺組織の治療のためのシステム及び方法
EP2352452A4 (fr) * 2008-11-06 2012-07-18 Nxthera Inc Systèmes et procédés de traitement de tissu prostatique
US8388611B2 (en) * 2009-01-14 2013-03-05 Nxthera, Inc. Systems and methods for treatment of prostatic tissue
US20100179416A1 (en) * 2009-01-14 2010-07-15 Michael Hoey Medical Systems and Methods
US11284931B2 (en) 2009-02-03 2022-03-29 Tsunami Medtech, Llc Medical systems and methods for ablating and absorbing tissue
US9833277B2 (en) 2009-04-27 2017-12-05 Nxthera, Inc. Systems and methods for prostate treatment
AU2010256775B2 (en) * 2009-06-01 2015-09-03 Channel Medsystems, Inc. Methods and apparatus for treatment of a body cavity or lumen
US20110092955A1 (en) 2009-10-07 2011-04-21 Purdy Phillip D Pressure-Sensing Medical Devices, Systems and Methods, and Methods of Forming Medical Devices
US8900223B2 (en) 2009-11-06 2014-12-02 Tsunami Medtech, Llc Tissue ablation systems and methods of use
US9161801B2 (en) * 2009-12-30 2015-10-20 Tsunami Medtech, Llc Medical system and method of use
AU2011230568B2 (en) * 2010-03-25 2016-02-18 Boston Scientific Scimed, Inc. Systems and methods for prostate treatment
WO2012006408A1 (fr) * 2010-07-08 2012-01-12 Given Imaging Ltd. Dispositif de pulvérisation pour cryothérapie
US9943353B2 (en) 2013-03-15 2018-04-17 Tsunami Medtech, Llc Medical system and method of use
US20120095371A1 (en) 2010-10-18 2012-04-19 CardioSonic Ltd. Ultrasound transducer and cooling thereof
US9566456B2 (en) * 2010-10-18 2017-02-14 CardioSonic Ltd. Ultrasound transceiver and cooling thereof
EP2629848B1 (fr) 2010-10-18 2014-10-08 Cardiosonic Ltd. Emetteur-récepteur d'ultrasons et maîtrise d'un processus d'endommagement thermique
US9028417B2 (en) 2010-10-18 2015-05-12 CardioSonic Ltd. Ultrasound emission element
ES2912362T3 (es) 2010-11-09 2022-05-25 Aegea Medical Inc Método de colocación y aparato para suministrar vapor al útero
WO2012099974A2 (fr) 2011-01-19 2012-07-26 Fractyl Laboratories, Inc. Dispositifs et procédés de traitement de tissus
AU2012212492B2 (en) 2011-02-01 2016-05-12 Channel Medsystems, Inc. Methods and apparatus for cryogenic treatment of a body cavity or lumen
US9439707B2 (en) 2011-03-25 2016-09-13 Medtronic Cryocath Lp Spray nozzle design for a catheter
EP2704799A4 (fr) * 2011-05-06 2014-10-29 Lankenau Inst Medical Res Compositions et procédés pour la prévention d'un cancer de l' sophage
PT2755614T (pt) 2011-09-13 2018-01-18 Nxthera Inc Sistemas de tratamento da próstata
WO2013052967A1 (fr) 2011-10-07 2013-04-11 Aegea Medical Inc. Procédé et appareil d'essai d'intégrité pour délivrer de la vapeur dans l'utérus
US10576278B2 (en) 2012-02-21 2020-03-03 Virender K. Sharma System and method for electrical stimulation of anorectal structures to treat urinary dysfunction
US8706234B2 (en) 2012-02-21 2014-04-22 Virender K. Sharma System and method for electrical stimulation of anorectal structures to treat anal dysfunction
US9782583B2 (en) 2012-02-21 2017-10-10 Virender K. Sharma System and method for electrical stimulation of anorectal structures to treat urinary dysfunction
WO2015077571A1 (fr) 2013-11-22 2015-05-28 Fractyl Laboratories, Inc. Systèmes, dispositifs et procédés pour la création d'une restriction thérapeutique dans le tractus gastro-intestinal
KR102245697B1 (ko) * 2012-02-27 2021-04-28 프랙틸 래브러토리스 인코포레이티드 조직의 치료를 위한 열 절제 시스템，장치 및 방법
WO2013152119A1 (fr) 2012-04-03 2013-10-10 Nxthera, Inc. Générateur de vapeur à bobine d'induction
US10357304B2 (en) 2012-04-18 2019-07-23 CardioSonic Ltd. Tissue treatment
KR102231179B1 (ko) 2012-04-19 2021-03-22 프랙틸 래브러토리스 인코포레이티드 조직 팽창 디바이스들, 시스템들, 및 방법들
US11357447B2 (en) 2012-05-31 2022-06-14 Sonivie Ltd. Method and/or apparatus for measuring renal denervation effectiveness
EP2879605A4 (fr) 2012-07-30 2016-04-06 Fractyl Lab Inc Systèmes, dispositifs et procédés d'ablation par énergie électrique pour le traitement de tissu
WO2014026055A1 (fr) 2012-08-09 2014-02-13 Fractyl Laboratories Inc. Systèmes, dispositifs et procédés d'ablation pour le traitement d'un tissu
EP2903626A4 (fr) 2012-10-05 2016-10-19 Fractyl Lab Inc Méthodes, systèmes et dispositifs pour la réalisation de traitements multiples sur un patient
EP2945556A4 (fr) 2013-01-17 2016-08-31 Virender K Sharma Procédé et appareil d'ablation de tissu
JP5757586B2 (ja) * 2013-02-28 2015-07-29 日本ライフライン株式会社 カテーテルシステム
JP2016513563A (ja) 2013-03-14 2016-05-16 エヌエックスセラ インコーポレイテッド 前立腺癌を治療するためのシステムおよび方法
US10219724B2 (en) 2013-05-02 2019-03-05 VS Medtech, Inc. Systems and methods for measuring and characterizing interior surfaces of luminal structures
WO2014188430A2 (fr) 2013-05-23 2014-11-27 CardioSonic Ltd. Dispositifs et procédés de dénervation rénale et évaluation associée
CA2913014C (fr) * 2013-05-23 2017-08-01 Channel Medsystems, Inc. Systemes de traitement cryogenique
WO2014197632A2 (fr) 2013-06-04 2014-12-11 Fractyl Laboratories, Inc. Procédés, systèmes et dispositifs pour réduire la surface luminale du tractus gastro-intestinal
AU2014240225A1 (en) 2013-10-01 2015-04-16 Uptake Medical Technology Inc. Preferential volume reduction of diseased segments of a heterogeneous lobe
US9968395B2 (en) 2013-12-10 2018-05-15 Nxthera, Inc. Systems and methods for treating the prostate
US10194970B2 (en) 2013-12-10 2019-02-05 Nxthera, Inc. Vapor ablation systems and methods
JP2017500144A (ja) * 2013-12-27 2017-01-05 レナルプロ・メディカル・インコーポレーテッドＲｅｎａｌｐｒｏ Ｍｅｄｉｃａｌ，Ｉｎｃ． 急性腎障害の治療用デバイスと治療方法
US10959774B2 (en) 2014-03-24 2021-03-30 Fractyl Laboratories, Inc. Injectate delivery devices, systems and methods
US9826936B2 (en) * 2014-04-03 2017-11-28 Beth Rosenshein Body cavity physiological measurement device
WO2015179662A1 (fr) 2014-05-22 2015-11-26 Aegea Medical Inc. Procédé de test d'intégrité et appareil pour acheminer de la vapeur dans l'utérus
WO2015179666A1 (fr) 2014-05-22 2015-11-26 Aegea Medical Inc. Systèmes et procédés pour l'ablation de l'endomètre
US11185367B2 (en) 2014-07-16 2021-11-30 Fractyl Health, Inc. Methods and systems for treating diabetes and related diseases and disorders
WO2016011269A1 (fr) 2014-07-16 2016-01-21 Fractyl Laboratories, Inc. Méthodes et systèmes de traitement du diabète et de maladies et troubles apparentés
US9844641B2 (en) 2014-07-16 2017-12-19 Fractyl Laboratories, Inc. Systems, devices and methods for performing medical procedures in the intestine
JP6929782B2 (ja) 2014-11-07 2021-09-01 レスピリックス，インコーポレイテッド 生理学的パラメータを求めるシステム
US10485604B2 (en) 2014-12-02 2019-11-26 Uptake Medical Technology Inc. Vapor treatment of lung nodules and tumors
EP3244820B1 (fr) * 2015-01-12 2020-06-24 Virender K. Sharma Appareil d'ablation de tissu
JP6757732B2 (ja) 2015-01-29 2020-09-23 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 蒸気切除システムおよび方法
US10531906B2 (en) 2015-02-02 2020-01-14 Uptake Medical Technology Inc. Medical vapor generator
WO2016145214A1 (fr) * 2015-03-10 2016-09-15 PAVmed Inc. Systèmes de cathéter à ballonnet à écoulement continu et procédés d'utilisation
WO2016183475A1 (fr) 2015-05-13 2016-11-17 Nxthera, Inc. Systèmes et procédés de traitement de la vessie avec de la vapeur condensable
US11213344B2 (en) * 2015-11-17 2022-01-04 Biosense Webster (Israel) Ltd. Guidewire with ablation and coagulation functionality
US10531907B2 (en) * 2015-11-20 2020-01-14 Covidien Lp Devices, systems, and methods for treating ulcerative colitis and other inflammatory bowel diseases
US10350423B2 (en) 2016-02-04 2019-07-16 Cardiac Pacemakers, Inc. Delivery system with force sensor for leadless cardiac device
CN114983553A (zh) * 2016-02-19 2022-09-02 埃杰亚医疗公司 用于确定体腔的完整性的方法和设备
CN114191067A (zh) * 2016-05-19 2022-03-18 圣安娜技术有限公司 整合冷却的消融导管
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
JP7129980B2 (ja) 2016-12-21 2022-09-02 ボストン サイエンティフィック サイムド，インコーポレイテッド 蒸気焼灼システム及び方法
JP7193463B2 (ja) 2017-01-06 2022-12-20 ボストン サイエンティフィック サイムド，インコーポレイテッド 経腹膜蒸気焼灼システム及び方法
WO2018173047A1 (fr) 2017-03-20 2018-09-27 Sonivie Ltd. Procédé de traitement d'une insuffisance cardiaque par amélioration de la fraction d'éjection d'un patient
US11129673B2 (en) 2017-05-05 2021-09-28 Uptake Medical Technology Inc. Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD
CN117503320A (zh) 2017-06-20 2024-02-06 埃杰亚医疗公司 用于子宫消融的感应线圈组件和方法
US11344364B2 (en) 2017-09-07 2022-05-31 Uptake Medical Technology Inc. Screening method for a target nerve to ablate for the treatment of inflammatory lung disease
US11350988B2 (en) 2017-09-11 2022-06-07 Uptake Medical Technology Inc. Bronchoscopic multimodality lung tumor treatment
USD845467S1 (en) 2017-09-17 2019-04-09 Uptake Medical Technology Inc. Hand-piece for medical ablation catheter
WO2019083764A1 (fr) * 2017-10-27 2019-05-02 St. Jude Medical, Cardiology Division, Inc. Système d'ablation par cryogénie
US11419658B2 (en) 2017-11-06 2022-08-23 Uptake Medical Technology Inc. Method for treating emphysema with condensable thermal vapor
EP3709917A4 (fr) * 2017-11-17 2021-07-28 CryoConcepts LP Dispositif cryochirurgical électromécanique portable
US11490946B2 (en) 2017-12-13 2022-11-08 Uptake Medical Technology Inc. Vapor ablation handpiece
US11311328B2 (en) 2018-05-16 2022-04-26 Imam Abdulrahman Bin Faisal University High-pressure steam-based surgical tool for cutting and hemostasis
CA3102080A1 (fr) 2018-06-01 2019-12-05 Santa Anna Tech Llc Procedes de traitement d'ablation a base de vapeur a plusieurs etapes et systemes de generation et de distribution de vapeur
US11950964B2 (en) 2019-02-15 2024-04-09 Gyrus Acmi, Inc. Medical device with mitigation for tissue perforation
US11653927B2 (en) 2019-02-18 2023-05-23 Uptake Medical Technology Inc. Vapor ablation treatment of obstructive lung disease
US11944842B2 (en) * 2019-12-20 2024-04-02 Gyrus Acmi, Inc. Photodynamic therapy device and methods of use
US20230098643A1 (en) * 2021-09-28 2023-03-30 Rheoxtech Llc Coronary ostial cardiac circulation isolation catheter and ventricular unloading reperfusion systems and methods
CN113796954B (zh) * 2021-10-11 2023-03-28 杭州市第一人民医院 一种可改变加热角度的消融针
CN113893024B (zh) * 2021-10-14 2023-09-05 江苏省肿瘤医院 一种方向可调式高温水蒸气消融针装置
CN115031219A (zh) * 2022-08-10 2022-09-09 浙江伽奈维医疗科技有限公司 一种蒸汽消融装置的蒸汽生成机构以及手枪

Family Cites Families (577)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US408899A (en) 1889-08-13 Island
US697181A (en) * 1901-08-20 1902-04-08 Lundy B Smith Instrument for cooling or for warming internal portions of the human body.
US1719750A (en) 1927-09-29 1929-07-02 Charles E Parkhurst Dental apparatus
US3938502A (en) * 1972-02-22 1976-02-17 Nicolaas Bom Apparatus with a catheter for examining hollow organs or bodies with the ultrasonic waves
US3818913A (en) 1972-08-30 1974-06-25 M Wallach Surgical apparatus for removal of tissue
US3924628A (en) 1972-12-01 1975-12-09 William Droegemueller Cyrogenic bladder for necrosing tissue cells
US3880168A (en) * 1973-12-21 1975-04-29 Robert A Berman Endotracheal tube
US3930505A (en) * 1974-06-24 1976-01-06 Hydro Pulse Corporation Surgical apparatus for removal of tissue
US4024866A (en) 1974-12-02 1977-05-24 Hydro Pulse Corporation Surgical apparatus for removal of tissue
US4083077A (en) * 1975-12-15 1978-04-11 Knight Arlen M Hand tool for cleaning fabric
US4701587A (en) 1979-08-31 1987-10-20 Metcal, Inc. Shielded heating element having intrinsic temperature control
US5542915A (en) 1992-08-12 1996-08-06 Vidamed, Inc. Thermal mapping catheter with ultrasound probe
US5421819A (en) 1992-08-12 1995-06-06 Vidamed, Inc. Medical probe device
US5385544A (en) 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus
US5435805A (en) 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
US5370675A (en) 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
US4672962A (en) 1983-09-28 1987-06-16 Cordis Corporation Plaque softening method
US4682596A (en) 1984-05-22 1987-07-28 Cordis Corporation Electrosurgical catheter and method for vascular applications
EP0192712A1 (fr) 1984-09-05 1986-09-03 Intra Optics Laboratories Pty. Limited Regulation d'un ecoulement de sang
US4773410A (en) 1984-10-09 1988-09-27 Transpirator Technologies, Inc. Method and apparatus for the treatment of the respiratory track with vapor-phase water
US4672963A (en) 1985-06-07 1987-06-16 Israel Barken Apparatus and method for computer controlled laser surgery
US4917084A (en) 1985-07-31 1990-04-17 C. R. Bard, Inc. Infrared laser catheter system
DE3686621T2 (de) 1985-07-31 1993-02-25 Bard Inc C R Infrarot laser-kathetergeraet.
US4748979A (en) 1985-10-07 1988-06-07 Cordis Corporation Plaque resolving device
US4793352A (en) 1986-02-07 1988-12-27 Eichenlaub John E Limited heat transfer device and method
DE3715418A1 (de) * 1986-05-08 1987-11-12 Olympus Optical Co Lithotom
US4872920A (en) 1987-11-25 1989-10-10 Flynn Tom S Asbestos removal method and system
JPH01139081A (ja) 1987-11-27 1989-05-31 Olympus Optical Co Ltd レーザ光照射装置
US5112328A (en) 1988-01-25 1992-05-12 Refractive Laser Research & Development Program, Ltd. Method and apparatus for laser surgery
US5328471A (en) * 1990-02-26 1994-07-12 Endoluminal Therapeutics, Inc. Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
US4915113A (en) 1988-12-16 1990-04-10 Bio-Vascular, Inc. Method and apparatus for monitoring the patency of vascular grafts
US5352512A (en) 1989-03-15 1994-10-04 The United States Of America As Represented By The Secretary Of The Air Force Microscopic tube material and its method of manufacture
US5011566A (en) * 1989-03-15 1991-04-30 The United States Of America As Represented By The Secretary Of The Air Force Method of manufacturing microscopic tube material
US4976711A (en) 1989-04-13 1990-12-11 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5263951A (en) 1989-04-21 1993-11-23 Kerus Medical Systems Correction of the optical focusing system of the eye using laser thermal keratoplasty
US5006119A (en) 1989-05-25 1991-04-09 Engineering & Research Associates, Inc. Hollow core coaxial catheter
US5084044A (en) 1989-07-14 1992-01-28 Ciron Corporation Apparatus for endometrial ablation and method of using same
US5562608A (en) 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
JP2935519B2 (ja) 1989-08-28 1999-08-16 シーキンス，ケイ・マイケル 超音波および／またはペルフルオロカーボン液での対流を介する肺癌高熱治療
US5045056A (en) 1989-09-15 1991-09-03 Behl Robert S Method and device for thermal ablation of hollow body organs
US5222938A (en) 1989-09-15 1993-06-29 Interventional Thermodynamics, Inc. Method for thermal ablation of hollow body organs
FR2655548A1 (fr) 1989-12-11 1991-06-14 Cleef Jean Francois Van Catheter a parois non lisses, catheter a parois moulurees.
US5084043A (en) 1990-01-12 1992-01-28 Laserscope Method for performing a percutaneous diskectomy using a laser
US4985027A (en) 1990-02-26 1991-01-15 Dressel Thomas D Soft tissue aspiration device and method
US5102410A (en) 1990-02-26 1992-04-07 Dressel Thomas D Soft tissue cutting aspiration device and method
US5624392A (en) 1990-05-11 1997-04-29 Saab; Mark A. Heat transfer catheters and methods of making and using same
US5190539A (en) 1990-07-10 1993-03-02 Texas A & M University System Micro-heat-pipe catheter
US5417686A (en) * 1990-07-10 1995-05-23 The Texas A&M University System Temperature control mechanisms for a micro heat pipe catheter
CA2048120A1 (fr) 1990-08-06 1992-02-07 William J. Drasler Methode et appareil de thrombectomie
AU647533B2 (en) 1990-10-16 1994-03-24 Summit Technology, Inc. Laser thermokeratoplasty methods and apparatus
US5122138A (en) 1990-11-28 1992-06-16 Manwaring Kim H Tissue vaporizing accessory and method for an endoscope
DK0561903T3 (da) 1990-12-10 1995-08-21 Howmedica Et middel og en fremgangsmåde til interstitiel laserenergiindføring
US5409453A (en) 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
WO1992017121A1 (fr) 1991-04-05 1992-10-15 Metcal, Inc. Instrument pour inciser, ablater et coaguler des tissus
US6113722A (en) 1991-04-24 2000-09-05 The United States Of America As Represented By The Secretary Of Air Force Microscopic tube devices and method of manufacture
US6194066B1 (en) 1991-04-24 2001-02-27 The United States Of America As Represented By The Secretary Of The Air Force Microscopic tube devices and method of manufacture
US5242390A (en) 1991-05-03 1993-09-07 Goldrath Milton H Endometrium coagulating surgical method for thermal destruction of the endometrium
EP0766533A1 (fr) 1991-05-17 1997-04-09 InnerDyne, Inc. Procede et dispositif d'ablation thermique
US5542928A (en) 1991-05-17 1996-08-06 Innerdyne, Inc. Method and device for thermal ablation having improved heat transfer
US5217459A (en) 1991-08-27 1993-06-08 William Kamerling Method and instrument for performing eye surgery
US5697281A (en) 1991-10-09 1997-12-16 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US5697909A (en) 1992-01-07 1997-12-16 Arthrocare Corporation Methods and apparatus for surgical cutting
US6461296B1 (en) 1998-06-26 2002-10-08 2000 Injectx, Inc. Method and apparatus for delivery of genes, enzymes and biological agents to tissue cells
US5524620A (en) 1991-11-12 1996-06-11 November Technologies Ltd. Ablation of blood thrombi by means of acoustic energy
DE4138115A1 (de) * 1991-11-19 1993-05-27 Delma Elektro Med App Medizinisches hochfrequenz-koagulationsinstrument
US6210402B1 (en) 1995-11-22 2001-04-03 Arthrocare Corporation Methods for electrosurgical dermatological treatment
US5683366A (en) * 1992-01-07 1997-11-04 Arthrocare Corporation System and method for electrosurgical tissue canalization
US6086585A (en) 1995-06-07 2000-07-11 Arthrocare Corporation System and methods for electrosurgical treatment of sleep obstructive disorders
US6109268A (en) 1995-06-07 2000-08-29 Arthrocare Corporation Systems and methods for electrosurgical endoscopic sinus surgery
US7429262B2 (en) 1992-01-07 2008-09-30 Arthrocare Corporation Apparatus and methods for electrosurgical ablation and resection of target tissue
US5902272A (en) 1992-01-07 1999-05-11 Arthrocare Corporation Planar ablation probe and method for electrosurgical cutting and ablation
US6063079A (en) 1995-06-07 2000-05-16 Arthrocare Corporation Methods for electrosurgical treatment of turbinates
US6053172A (en) 1995-06-07 2000-04-25 Arthrocare Corporation Systems and methods for electrosurgical sinus surgery
US5891095A (en) 1993-05-10 1999-04-06 Arthrocare Corporation Electrosurgical treatment of tissue in electrically conductive fluid
US6974453B2 (en) 1993-05-10 2005-12-13 Arthrocare Corporation Dual mode electrosurgical clamping probe and related methods
US6190381B1 (en) 1995-06-07 2001-02-20 Arthrocare Corporation Methods for tissue resection, ablation and aspiration
US7297145B2 (en) 1997-10-23 2007-11-20 Arthrocare Corporation Bipolar electrosurgical clamp for removing and modifying tissue
US6277112B1 (en) 1996-07-16 2001-08-21 Arthrocare Corporation Methods for electrosurgical spine surgery
US5681282A (en) 1992-01-07 1997-10-28 Arthrocare Corporation Methods and apparatus for ablation of luminal tissues
US5843019A (en) 1992-01-07 1998-12-01 Arthrocare Corporation Shaped electrodes and methods for electrosurgical cutting and ablation
US6183469B1 (en) 1997-08-27 2001-02-06 Arthrocare Corporation Electrosurgical systems and methods for the removal of pacemaker leads
US6296638B1 (en) 1993-05-10 2001-10-02 Arthrocare Corporation Systems for tissue ablation and aspiration
US6142992A (en) 1993-05-10 2000-11-07 Arthrocare Corporation Power supply for limiting power in electrosurgery
US6024733A (en) 1995-06-07 2000-02-15 Arthrocare Corporation System and method for epidermal tissue ablation
US5697882A (en) 1992-01-07 1997-12-16 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US6500173B2 (en) 1992-01-07 2002-12-31 Ronald A. Underwood Methods for electrosurgical spine surgery
US6159194A (en) 1992-01-07 2000-12-12 Arthrocare Corporation System and method for electrosurgical tissue contraction
US6102046A (en) 1995-11-22 2000-08-15 Arthrocare Corporation Systems and methods for electrosurgical tissue revascularization
US6770071B2 (en) 1995-06-07 2004-08-03 Arthrocare Corporation Bladed electrosurgical probe
US6179824B1 (en) 1993-05-10 2001-01-30 Arthrocare Corporation System and methods for electrosurgical restenosis of body lumens
US6355032B1 (en) 1995-06-07 2002-03-12 Arthrocare Corporation Systems and methods for selective electrosurgical treatment of body structures
US5217465A (en) 1992-02-28 1993-06-08 Alcon Surgical, Inc. Flexible and steerable aspiration tip for microsurgery
US5330518A (en) 1992-03-06 1994-07-19 Urologix, Inc. Method for treating interstitial tissue associated with microwave thermal therapy
US5443470A (en) 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
US5331947A (en) 1992-05-01 1994-07-26 Shturman Cardiology Systems, Inc. Inflatable sheath for introduction of ultrasonic catheter through the lumen of a fiber optic endoscope
US5344397A (en) 1992-06-26 1994-09-06 Advanced Surgical, Inc. Cholangiogram catheter
WO1994002077A2 (fr) * 1992-07-15 1994-02-03 Angelase, Inc. Systeme de catheter pour ablation
US5354331A (en) 1992-07-15 1994-10-11 Schachar Ronald A Treatment of presbyopia and other eye disorders
US5470308A (en) 1992-08-12 1995-11-28 Vidamed, Inc. Medical probe with biopsy stylet
US5672153A (en) 1992-08-12 1997-09-30 Vidamed, Inc. Medical probe device and method
US5542916A (en) 1992-08-12 1996-08-06 Vidamed, Inc. Dual-channel RF power delivery system
US5556377A (en) 1992-08-12 1996-09-17 Vidamed, Inc. Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe
US5667488A (en) 1992-08-12 1997-09-16 Vidamed, Inc. Transurethral needle ablation device and method for the treatment of the prostate
US5484400A (en) 1992-08-12 1996-01-16 Vidamed, Inc. Dual channel RF delivery system
US5630794A (en) 1992-08-12 1997-05-20 Vidamed, Inc. Catheter tip and method of manufacturing
US5720718A (en) 1992-08-12 1998-02-24 Vidamed, Inc. Medical probe apparatus with enhanced RF, resistance heating, and microwave ablation capabilities
US5720719A (en) 1992-08-12 1998-02-24 Vidamed, Inc. Ablative catheter with conformable body
US5425931A (en) 1992-09-04 1995-06-20 Nippon Steel Corporation Small diameter pitch-based carbon fiber bundle and production method thereof
US5318014A (en) 1992-09-14 1994-06-07 Coraje, Inc. Ultrasonic ablation/dissolution transducer
US5312399A (en) 1992-09-29 1994-05-17 Hakky Said I Laser resectoscope with mechanical cutting means and laser coagulating means
DE4338758C2 (de) * 1992-11-13 2001-08-09 Scimed Life Systems Inc Katheteranordnung
CA2155217A1 (fr) 1993-02-02 1994-08-18 Ingemar H. Lundquist Dispositif d'ablation transuretral a aiguille; methode d'emploi
US6915806B2 (en) 1993-05-10 2005-07-12 Arthrocare Corporation Method for harvesting graft vessel
US6749604B1 (en) 1993-05-10 2004-06-15 Arthrocare Corporation Electrosurgical instrument with axially-spaced electrodes
US6832996B2 (en) 1995-06-07 2004-12-21 Arthrocare Corporation Electrosurgical systems and methods for treating tissue
US6254600B1 (en) 1993-05-10 2001-07-03 Arthrocare Corporation Systems for tissue ablation and aspiration
US6235020B1 (en) 1993-05-10 2001-05-22 Arthrocare Corporation Power supply and methods for fluid delivery in electrosurgery
US6117109A (en) 1995-11-22 2000-09-12 Arthrocare Corporation Systems and methods for electrosurgical incisions on external skin surfaces
US6896674B1 (en) 1993-05-10 2005-05-24 Arthrocare Corporation Electrosurgical apparatus having digestion electrode and methods related thereto
US6391025B1 (en) 1993-05-10 2002-05-21 Arthrocare Corporation Electrosurgical scalpel and methods for tissue cutting
EP0703756B1 (fr) 1993-06-10 2004-12-15 IMRAN, Mir, A. Appareil transurethral d'ablation a frequence radio
US5431649A (en) 1993-08-27 1995-07-11 Medtronic, Inc. Method and apparatus for R-F ablation
US5980516A (en) 1993-08-27 1999-11-09 Medtronic, Inc. Method and apparatus for R-F ablation
US5405376A (en) 1993-08-27 1995-04-11 Medtronic, Inc. Method and apparatus for ablation
US5449380A (en) 1993-09-17 1995-09-12 Origin Medsystems, Inc. Apparatus and method for organ ablation
US6056738A (en) 1997-01-31 2000-05-02 Transmedica International, Inc. Interstitial fluid monitoring
KR0141224B1 (ko) 1993-10-11 1998-06-01 김광호 고속출화형 디스플레이장치
US5797903A (en) 1996-04-12 1998-08-25 Ep Technologies, Inc. Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces
US5433739A (en) 1993-11-02 1995-07-18 Sluijter; Menno E. Method and apparatus for heating an intervertebral disc for relief of back pain
DE4338866C1 (de) 1993-11-13 1995-06-14 Wolf Gmbh Richard Medizinisches Instrument zur Applikation von Heißgas
US5462521A (en) 1993-12-21 1995-10-31 Angeion Corporation Fluid cooled and perfused tip for a catheter
US5503638A (en) 1994-02-10 1996-04-02 Bio-Vascular, Inc. Soft tissue stapling buttress
CA2186478C (fr) * 1994-04-14 2001-04-10 Milton H. Goldrath Systeme d'alimentation en liquide utilise en chirurgie hysteroscopique
US5437629A (en) 1994-04-14 1995-08-01 Bei Medical Systems Fluid delivery system for hysteroscopic endometrial ablation
US5730719A (en) 1994-05-09 1998-03-24 Somnus Medical Technologies, Inc. Method and apparatus for cosmetically remodeling a body structure
US5674191A (en) 1994-05-09 1997-10-07 Somnus Medical Technologies, Inc. Ablation apparatus and system for removal of soft palate tissue
US5743870A (en) 1994-05-09 1998-04-28 Somnus Medical Technologies, Inc. Ablation apparatus and system for removal of soft palate tissue
US5707349A (en) 1994-05-09 1998-01-13 Somnus Medical Technologies, Inc. Method for treatment of air way obstructions
US5824703A (en) 1994-05-13 1998-10-20 Synthetic Blood International, Inc. Method of assisting normal breathing in a mammal having a lung disorder
US6002968A (en) 1994-06-24 1999-12-14 Vidacare, Inc. Uterine treatment apparatus
US5540658A (en) * 1994-06-27 1996-07-30 Innerdyne, Inc. Transcervical uterine access and sealing device
US5591157A (en) * 1994-09-07 1997-01-07 Hennings; David R. Method and apparatus for tympanic membrane shrinkage
US5609151A (en) 1994-09-08 1997-03-11 Medtronic, Inc. Method for R-F ablation
US8025661B2 (en) 1994-09-09 2011-09-27 Cardiofocus, Inc. Coaxial catheter instruments for ablation with radiant energy
US5545171A (en) 1994-09-22 1996-08-13 Vidamed, Inc. Anastomosis catheter
US5601591A (en) 1994-09-23 1997-02-11 Vidamed, Inc. Stent for use in prostatic urethra, apparatus and placement device for same and method
US5558673A (en) 1994-09-30 1996-09-24 Vidamed, Inc. Medical probe device and method having a flexible resilient tape stylet
WO1996010366A1 (fr) 1994-10-03 1996-04-11 Heart Technology, Inc. Appareil permettant une thrombectomie transluminale
US5783046A (en) 1994-11-28 1998-07-21 Gentech, Inc. Process and apparatus for the destructive distillation of rubber
US5588960A (en) 1994-12-01 1996-12-31 Vidamed, Inc. Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence
US6544211B1 (en) * 1995-02-06 2003-04-08 Mark S. Andrew Tissue liquefaction and aspiration
US6676629B2 (en) 1995-02-06 2004-01-13 Mark S. Andrew Tissue liquefaction and aspiration for dental treatment
US5616120A (en) * 1995-02-06 1997-04-01 Andrew; Mark S. Method and apparatus for lenticular liquefaction and aspiration
US5669907A (en) 1995-02-10 1997-09-23 Valleylab Inc. Plasma enhanced bipolar electrosurgical system
US5897553A (en) 1995-11-02 1999-04-27 Medtronic, Inc. Ball point fluid-assisted electrocautery device
US6063081A (en) 1995-02-22 2000-05-16 Medtronic, Inc. Fluid-assisted electrocautery device
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US5672290A (en) 1995-03-13 1997-09-30 Raychem Corporation Power source and method for induction heating of articles
US6203542B1 (en) 1995-06-07 2001-03-20 Arthrocare Corporation Method for electrosurgical treatment of submucosal tissue
US6159208A (en) 1995-06-07 2000-12-12 Arthocare Corporation System and methods for electrosurgical treatment of obstructive sleep disorders
US6602248B1 (en) 1995-06-07 2003-08-05 Arthro Care Corp. Methods for repairing damaged intervertebral discs
US6264650B1 (en) 1995-06-07 2001-07-24 Arthrocare Corporation Methods for electrosurgical treatment of intervertebral discs
US5800493A (en) 1995-04-26 1998-09-01 Gynecare, Inc. Intrauterine ablation system
US5755753A (en) 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US5554172A (en) 1995-05-09 1996-09-10 The Larren Corporation Directed energy surgical method and assembly
US6837887B2 (en) 1995-06-07 2005-01-04 Arthrocare Corporation Articulated electrosurgical probe and methods
US6149620A (en) 1995-11-22 2000-11-21 Arthrocare Corporation System and methods for electrosurgical tissue treatment in the presence of electrically conductive fluid
US5741248A (en) * 1995-06-07 1998-04-21 Temple University-Of The Commonwealth System Of Higher Education Fluorochemical liquid augmented cryosurgery
US6632193B1 (en) 1995-06-07 2003-10-14 Arthrocare Corporation Systems and methods for electrosurgical tissue treatment
US6837888B2 (en) 1995-06-07 2005-01-04 Arthrocare Corporation Electrosurgical probe with movable return electrode and methods related thereto
US6238391B1 (en) 1995-06-07 2001-05-29 Arthrocare Corporation Systems for tissue resection, ablation and aspiration
US6363937B1 (en) 1995-06-07 2002-04-02 Arthrocare Corporation System and methods for electrosurgical treatment of the digestive system
US5944686A (en) 1995-06-07 1999-08-31 Hydrocision, Inc. Instrument for creating a fluid jet
US6772012B2 (en) 1995-06-07 2004-08-03 Arthrocare Corporation Methods for electrosurgical treatment of spinal tissue
US7179255B2 (en) 1995-06-07 2007-02-20 Arthrocare Corporation Methods for targeted electrosurgery on contained herniated discs
US20050004634A1 (en) * 1995-06-07 2005-01-06 Arthrocare Corporation Methods for electrosurgical treatment of spinal tissue
US5992769A (en) 1995-06-09 1999-11-30 The Regents Of The University Of Michigan Microchannel system for fluid delivery
US6607529B1 (en) 1995-06-19 2003-08-19 Medtronic Vidamed, Inc. Electrosurgical device
US5849011A (en) 1995-06-19 1998-12-15 Vidamed, Inc. Medical device with trigger actuation assembly
US6015406A (en) 1996-01-09 2000-01-18 Gyrus Medical Limited Electrosurgical instrument
US6293942B1 (en) 1995-06-23 2001-09-25 Gyrus Medical Limited Electrosurgical generator method
CA2224858C (fr) 1995-06-23 2006-11-14 Gyrus Medical Limited Instrument electrochirurgical
US6780180B1 (en) 1995-06-23 2004-08-24 Gyrus Medical Limited Electrosurgical instrument
CA2224975A1 (fr) 1995-06-23 1997-01-09 Gyrus Medical Limited Instrument electrochirurgical
US6254597B1 (en) 1995-08-31 2001-07-03 Biolase Technology, Inc. Tissue remover and method
US6669685B1 (en) 1997-11-06 2003-12-30 Biolase Technology, Inc. Tissue remover and method
US6231567B1 (en) 1995-08-31 2001-05-15 Biolase Technology Inc. Material remover and method
US5741247A (en) 1995-08-31 1998-04-21 Biolase Technology, Inc. Atomized fluid particles for electromagnetically induced cutting
US5785521A (en) 1995-08-31 1998-07-28 Biolase Technology, Inc. Fluid conditioning system
US5700262A (en) 1995-10-16 1997-12-23 Neuro Navigational, L.L.C. Bipolar electrode with fluid channels for less invasive neurosurgery
US6073051A (en) 1996-08-13 2000-06-06 Oratec Interventions, Inc. Apparatus for treating intervertebal discs with electromagnetic energy
US6461350B1 (en) 1995-11-22 2002-10-08 Arthrocare Corporation Systems and methods for electrosurgical-assisted lipectomy
US6228078B1 (en) 1995-11-22 2001-05-08 Arthrocare Corporation Methods for electrosurgical dermatological treatment
US6896672B1 (en) 1995-11-22 2005-05-24 Arthrocare Corporation Methods for electrosurgical incisions on external skin surfaces
US7186234B2 (en) 1995-11-22 2007-03-06 Arthrocare Corporation Electrosurgical apparatus and methods for treatment and removal of tissue
US6805130B2 (en) 1995-11-22 2004-10-19 Arthrocare Corporation Methods for electrosurgical tendon vascularization
US6228082B1 (en) 1995-11-22 2001-05-08 Arthrocare Corporation Systems and methods for electrosurgical treatment of vascular disorders
US5735811A (en) 1995-11-30 1998-04-07 Pharmasonics, Inc. Apparatus and methods for ultrasonically enhanced fluid delivery
US6013076A (en) 1996-01-09 2000-01-11 Gyrus Medical Limited Electrosurgical instrument
US6036713A (en) 1996-01-24 2000-03-14 Archimedes Surgical, Inc. Instruments and methods for minimally invasive vascular procedures
US5820580A (en) 1996-02-23 1998-10-13 Somnus Medical Technologies, Inc. Method for ablating interior sections of the tongue
US5800379A (en) 1996-02-23 1998-09-01 Sommus Medical Technologies, Inc. Method for ablating interior sections of the tongue
US5800482A (en) 1996-03-06 1998-09-01 Cardiac Pathways Corporation Apparatus and method for linear lesion ablation
US6032077A (en) 1996-03-06 2000-02-29 Cardiac Pathways Corporation Ablation catheter with electrical coupling via foam drenched with a conductive fluid
US5830179A (en) 1996-04-09 1998-11-03 Endocare, Inc. Urological stent therapy system and method
US6813520B2 (en) 1996-04-12 2004-11-02 Novacept Method for ablating and/or coagulating tissue using moisture transport
US5769880A (en) 1996-04-12 1998-06-23 Novacept Moisture transport system for contact electrocoagulation
US7604633B2 (en) * 1996-04-12 2009-10-20 Cytyc Corporation Moisture transport system for contact electrocoagulation
US5989249A (en) 1996-04-29 1999-11-23 Kirwan Surgical Products, Inc. Bipolar suction coagulator
US6077257A (en) 1996-05-06 2000-06-20 Vidacare, Inc. Ablation of rectal and other internal body structures
US6419673B1 (en) * 1996-05-06 2002-07-16 Stuart Edwards Ablation of rectal and other internal body structures
US20050245894A1 (en) * 1996-05-20 2005-11-03 Medtronic Vascular, Inc. Methods and apparatuses for drug delivery to an intravascular occlusion
IT1283090B1 (it) 1996-06-04 1998-04-07 Imr Srl Impianto di colata in conchiglia a bassa pressione,a potenzialita' incrementata
GB2314274A (en) 1996-06-20 1997-12-24 Gyrus Medical Ltd Electrode construction for an electrosurgical instrument
GB9612993D0 (en) 1996-06-20 1996-08-21 Gyrus Medical Ltd Electrosurgical instrument
US7357798B2 (en) 1996-07-16 2008-04-15 Arthrocare Corporation Systems and methods for electrosurgical prevention of disc herniations
US7104986B2 (en) 1996-07-16 2006-09-12 Arthrocare Corporation Intervertebral disc replacement method
US6726684B1 (en) 1996-07-16 2004-04-27 Arthrocare Corporation Methods for electrosurgical spine surgery
US5976123A (en) 1996-07-30 1999-11-02 Laser Aesthetics, Inc. Heart stabilization
US6102885A (en) 1996-08-08 2000-08-15 Bass; Lawrence S. Device for suction-assisted lipectomy and method of using same
US6126682A (en) * 1996-08-13 2000-10-03 Oratec Interventions, Inc. Method for treating annular fissures in intervertebral discs
US5891134A (en) * 1996-09-24 1999-04-06 Goble; Colin System and method for applying thermal energy to tissue
CA2266073C (fr) 1996-10-02 2006-08-08 Medtronic, Inc. Instrument a fluide pour electrocauterisation
US5986662A (en) 1996-10-16 1999-11-16 Vital Images, Inc. Advanced diagnostic viewer employing automated protocol selection for volume-rendered imaging
US5752965A (en) 1996-10-21 1998-05-19 Bio-Vascular, Inc. Apparatus and method for producing a reinforced surgical fastener suture line
US6719755B2 (en) 1996-10-22 2004-04-13 Epicor Medical, Inc. Methods and devices for ablation
US5827268A (en) 1996-10-30 1998-10-27 Hearten Medical, Inc. Device for the treatment of patent ductus arteriosus and method of using the device
US5954714A (en) * 1996-11-20 1999-09-21 Gynecare, Inc. Heated balloon having rotary fluid impeller
US5782914A (en) 1996-11-29 1998-07-21 Bio-Vascular, Inc. Method for preparing heterogeneous tissue grafts
US5885243A (en) * 1996-12-11 1999-03-23 Alcon Laboratories, Inc. Liquefaction handpiece
US6394996B1 (en) 1997-01-07 2002-05-28 C. R. Bard, Inc. System for aspirating and irrigating tract wounds
US5879329A (en) 1997-01-22 1999-03-09 Radiant Medical, Inc. Infusion systems and methods for introducing fluids into the body within a desired temperature range
US5861005A (en) 1997-02-11 1999-01-19 X-Site, L.L.C. Arterial stapling device
US6699244B2 (en) 1997-02-12 2004-03-02 Oratec Interventions, Inc. Electrosurgical instrument having a chamber to volatize a liquid
US6086582A (en) 1997-03-13 2000-07-11 Altman; Peter A. Cardiac drug delivery system
US6017361A (en) 1997-03-13 2000-01-25 Endo Care, Inc. Urethral warming catheter
US6300150B1 (en) 1997-03-31 2001-10-09 Research Triangle Institute Thin-film thermoelectric device and fabrication method of same
US6200333B1 (en) 1997-04-07 2001-03-13 Broncus Technologies, Inc. Bronchial stenter
US6634363B1 (en) 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US6488673B1 (en) 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US6273907B1 (en) 1997-04-07 2001-08-14 Broncus Technologies, Inc. Bronchial stenter
US6083255A (en) 1997-04-07 2000-07-04 Broncus Technologies, Inc. Bronchial stenter
US5972026A (en) 1997-04-07 1999-10-26 Broncus Technologies, Inc. Bronchial stenter having diametrically adjustable electrodes
US5873877A (en) 1997-04-11 1999-02-23 Vidamed, Inc. Medical probe device with transparent distal extremity
US5964756A (en) 1997-04-11 1999-10-12 Vidamed, Inc. Transurethral needle ablation device with replaceable stylet cartridge
US5871481A (en) 1997-04-11 1999-02-16 Vidamed, Inc. Tissue ablation apparatus and method
US5891457A (en) 1997-05-12 1999-04-06 Neuwirth; Robert S. Intrauterine chemical necrosing method, composition, and apparatus
US5913856A (en) 1997-05-19 1999-06-22 Irvine Biomedical, Inc. Catheter system having a porous shaft and fluid irrigation capabilities
US7025762B2 (en) 1997-05-23 2006-04-11 Crymed Technologies, Inc. Method and apparatus for cryogenic spray ablation of gastrointestinal mucosa
CA2287206A1 (fr) 1997-06-13 1998-12-17 Arthrocare Corporation Systemes electro-chirurgicaux et procedes de recanalisation de passages corporels occlus
US5938660A (en) 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
US5957919A (en) 1997-07-02 1999-09-28 Laufer; Michael D. Bleb reducer
US6652515B1 (en) 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
ATE433306T1 (de) 1997-07-08 2009-06-15 Univ California Vorrichtung zur zirkumferenziellen ablation
US6139571A (en) 1997-07-09 2000-10-31 Fuller Research Corporation Heated fluid surgical instrument
US6096037A (en) 1997-07-29 2000-08-01 Medtronic, Inc. Tissue sealing electrosurgery device and methods of sealing tissue
US6080151A (en) 1997-07-21 2000-06-27 Daig Corporation Ablation catheter
EP1014873A4 (fr) 1997-09-22 2003-07-09 Ethicon Inc Systeme et procede de cryochirurgie
US6238389B1 (en) * 1997-09-30 2001-05-29 Boston Scientific Corporation Deflectable interstitial ablation device
US6045549A (en) 1997-09-30 2000-04-04 Somnus Medical Technologies, Inc. Tissue ablation apparatus and device for use therein and method
US7094215B2 (en) 1997-10-02 2006-08-22 Arthrocare Corporation Systems and methods for electrosurgical tissue contraction
US6139538A (en) 1997-10-06 2000-10-31 Iotek, Inc. Iontophoretic agent delivery to the female reproductive tract
WO1999022656A1 (fr) 1997-10-30 1999-05-14 Sonique Surgical Systems, Inc. Procede et appareil de liposuccion assiste par laser
US6130671A (en) 1997-11-26 2000-10-10 Vital Images, Inc. Volume rendering lighting using dot product methodology
US5964752A (en) 1998-02-02 1999-10-12 Stone; Kevin R. Articular cartilage surface shaping apparatus and method
US6440127B2 (en) 1998-02-11 2002-08-27 Cosman Company, Inc. Method for performing intraurethral radio-frequency urethral enlargement
US6258087B1 (en) 1998-02-19 2001-07-10 Curon Medical, Inc. Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions
US6045532A (en) 1998-02-20 2000-04-04 Arthrocare Corporation Systems and methods for electrosurgical treatment of tissue in the brain and spinal cord
EP1063951B1 (fr) 1998-03-17 2009-09-16 Gary S. Kochamba Appareil de stabilisation de tissus
DE69900864T2 (de) 1998-03-23 2002-09-05 Bio Vascular Inc Implantate und verfahren zu deren herstellung
GB9807303D0 (en) 1998-04-03 1998-06-03 Gyrus Medical Ltd An electrode assembly for an electrosurgical instrument
US6911028B2 (en) 1998-10-28 2005-06-28 John H. Shadduck Medical instrument working end and method for endoluminal treatments
US6508816B2 (en) 1998-03-27 2003-01-21 John H. Shadduck Medical instrument working end creating very high pressure gradients
US8016823B2 (en) * 2003-01-18 2011-09-13 Tsunami Medtech, Llc Medical instrument and method of use
US6053909A (en) 1998-03-27 2000-04-25 Shadduck; John H. Ionothermal delivery system and technique for medical procedures
US7892229B2 (en) 2003-01-18 2011-02-22 Tsunami Medtech, Llc Medical instruments and techniques for treating pulmonary disorders
US7674259B2 (en) * 2000-12-09 2010-03-09 Tsunami Medtech Medical instruments and techniques for thermally-mediated therapies
US6210404B1 (en) 1998-10-28 2001-04-03 John H. Shadduck Microjoule electrical discharge catheter for thrombolysis in stroke patients
US6669694B2 (en) * 2000-09-05 2003-12-30 John H. Shadduck Medical instruments and techniques for highly-localized thermally-mediated therapies
US6047700A (en) 1998-03-30 2000-04-11 Arthrocare Corporation Systems and methods for electrosurgical removal of calcified deposits
US6522930B1 (en) * 1998-05-06 2003-02-18 Atrionix, Inc. Irrigated ablation device assembly
US6327505B1 (en) 1998-05-07 2001-12-04 Medtronic, Inc. Method and apparatus for rf intraluminal reduction and occlusion
US6493589B1 (en) 1998-05-07 2002-12-10 Medtronic, Inc. Methods and apparatus for treatment of pulmonary conditions
US6216703B1 (en) 1998-05-08 2001-04-17 Thermatrx, Inc. Therapeutic prostatic thermotherapy
US6740082B2 (en) 1998-12-29 2004-05-25 John H. Shadduck Surgical instruments for treating gastro-esophageal reflux
US6763836B2 (en) 1998-06-02 2004-07-20 Arthrocare Corporation Methods for electrosurgical tendon vascularization
US6080128A (en) 1998-06-04 2000-06-27 Alcon Laboratories, Inc. Liquefaction handpiece
US6676628B2 (en) * 1998-06-04 2004-01-13 Alcon Manufacturing, Ltd. Pumping chamber for a liquefracture handpiece
US6589201B1 (en) 1998-06-04 2003-07-08 Alcon Manufacturing, Ltd. Liquefracture handpiece tip
US6398759B1 (en) 1998-06-04 2002-06-04 Alcon Manufacturing, Ltd. Liquefracture handpiece tip
US6331171B1 (en) 1998-06-04 2001-12-18 Alcon Laboratories, Inc. Tip for a liquefracture handpiece
US6860868B1 (en) 1998-06-04 2005-03-01 Alcon Manufacturing, Ltd. Surgical handpiece
US5989212A (en) 1998-06-04 1999-11-23 Alcon Laboratories, Inc. Pumping chamber for a liquefaction handpiece having a countersink electrode
US5997499A (en) 1998-06-04 1999-12-07 Alcon Laboratories, Inc. Tip for a liquefaction handpiece
US6179805B1 (en) * 1998-06-04 2001-01-30 Alcon Laboratories, Inc. Liquefracture handpiece
US6579270B2 (en) 1998-06-04 2003-06-17 Alcon Manufacturing, Ltd. Liquefracture handpiece tip
US6315755B1 (en) 1998-06-04 2001-11-13 Alcon Manufacturing, Ltd. Method of controlling a liquefracture handpiece
US20020161326A1 (en) 1998-06-04 2002-10-31 Glenn Sussman Tip for a liquefracture handpiece
US6196989B1 (en) * 1998-06-04 2001-03-06 Alcon Laboratories, Inc. Tip for liquefracture handpiece
US6206848B1 (en) * 1998-06-04 2001-03-27 Alcon Laboratories, Inc. Liquefracture handpiece
US6599311B1 (en) 1998-06-05 2003-07-29 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6066132A (en) 1998-06-30 2000-05-23 Ethicon, Inc. Articulating endometrial ablation device
US6099251A (en) 1998-07-06 2000-08-08 United Technologies Corporation Coolable airfoil for a gas turbine engine
US6112123A (en) * 1998-07-28 2000-08-29 Endonetics, Inc. Device and method for ablation of tissue
US7276063B2 (en) 1998-08-11 2007-10-02 Arthrocare Corporation Instrument for electrosurgical tissue treatment
US7435247B2 (en) 1998-08-11 2008-10-14 Arthrocare Corporation Systems and methods for electrosurgical tissue treatment
WO2000019926A1 (fr) 1998-10-05 2000-04-13 Scimed Life Systems, Inc. Ablation thermique d'une surface etendue
ATE315948T1 (de) 1998-11-17 2006-02-15 Henri Mehier Vorrichtung zum einführen eines medikaments in einer gewebsmembran, implantationsvorrichtung und injektionsvorrichtung
GB9828696D0 (en) 1998-12-29 1999-02-17 Houston J G Blood-flow tubing
US6113593A (en) 1999-02-01 2000-09-05 Tu; Lily Chen Ablation apparatus having temperature and force sensing capabilities
US6458231B1 (en) 1999-03-17 2002-10-01 The United States Of America As Represented By The Secretary Of The Air Force Method of making microtubes with axially variable geometries
US6162232A (en) 1999-03-18 2000-12-19 Shadduck; John H. Instruments and techniques for high-velocity fluid abrasion of epidermal layers with skin cooling
US6299620B1 (en) 1999-03-18 2001-10-09 Aq Technologies, Inc. Instruments and techniques for inducing neocollagenesis in skin treatments
DE19912844A1 (de) 1999-03-22 2000-09-28 Saphir Medical Products Gmbh Verwendung eines Schneidegerätes, welches ein Fluid als Schneidemedium einsetzt, zur chirurgischen Behandlung
US6409723B1 (en) 1999-04-02 2002-06-25 Stuart D. Edwards Treating body tissue by applying energy and substances
AU4666900A (en) * 1999-04-28 2000-11-10 Georgia Tech Research Corporation Instrument and method for phacoemulsification by direct thermal irradiation
CA2369312C (fr) 1999-05-11 2009-11-24 Atrionix, Inc. Fil d'ancrage de ballonnet
US6375635B1 (en) 1999-05-18 2002-04-23 Hydrocision, Inc. Fluid jet surgical instruments
GB9911956D0 (en) 1999-05-21 1999-07-21 Gyrus Medical Ltd Electrosurgery system and method
US6156036A (en) 1999-06-11 2000-12-05 Alcon Laboratories, Inc. Surgical handpiece tip
US6712812B2 (en) * 1999-08-05 2004-03-30 Broncus Technologies, Inc. Devices for creating collateral channels
US7022088B2 (en) 1999-08-05 2006-04-04 Broncus Technologies, Inc. Devices for applying energy to tissue
EP1400204A1 (fr) 1999-08-05 2004-03-24 Broncus Technologies, Inc. Procédés et dispositifs permettant de créer des canaux collatéraux dans les poumons
US6610043B1 (en) 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
US20020087155A1 (en) 1999-08-30 2002-07-04 Underwood Ronald A. Systems and methods for intradermal collagen stimulation
US6312474B1 (en) 1999-09-15 2001-11-06 Bio-Vascular, Inc. Resorbable implant materials
AU775490B2 (en) 1999-10-05 2004-08-05 Omnisonics Medical Technologies, Inc. Method and apparatus for ultrasonic medical treatment, in particular, for debulking the prostate
US6379350B1 (en) 1999-10-05 2002-04-30 Oratec Interventions, Inc. Surgical instrument for ablation and aspiration
WO2001026570A1 (fr) 1999-10-13 2001-04-19 Arthrocare Corporation Systemes et methodes de traitement de la douleur spinale
WO2001026721A1 (fr) 1999-10-14 2001-04-19 The Trustees Of Boston University Procede et systeme de ventilation a pointe de pression variable
US6398775B1 (en) 1999-10-21 2002-06-04 Pulmonx Apparatus and method for isolated lung access
US20060095032A1 (en) * 1999-11-16 2006-05-04 Jerome Jackson Methods and systems for determining physiologic characteristics for treatment of the esophagus
GB9927338D0 (en) 1999-11-18 2000-01-12 Gyrus Medical Ltd Electrosurgical system
US6575932B1 (en) * 1999-12-02 2003-06-10 Ottawa Heart Institute Adjustable multi-balloon local delivery device
US6277130B1 (en) 1999-12-14 2001-08-21 John H. Shadduck Electrical discharge surgical fastener for meniscal repairs
US20020013601A1 (en) 2000-01-28 2002-01-31 Nobles Anthony A. Cavity enlarger method and apparatus
US6758846B2 (en) 2000-02-08 2004-07-06 Gyrus Medical Limited Electrosurgical instrument and an electrosurgery system including such an instrument
US6558314B1 (en) 2000-02-11 2003-05-06 Iotek, Inc. Devices and method for manipulation of organ tissue
US6629974B2 (en) 2000-02-22 2003-10-07 Gyrus Medical Limited Tissue treatment method
US6673071B2 (en) 2000-02-24 2004-01-06 Vandusseldorp Gregg A. Partial ablation procedure and device therefor
US6551274B2 (en) 2000-02-29 2003-04-22 Biosense Webster, Inc. Cryoablation catheter with an expandable cooling chamber
US6443947B1 (en) 2000-03-01 2002-09-03 Alexei Marko Device for thermal ablation of a cavity
US6679264B1 (en) * 2000-03-04 2004-01-20 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US20030070683A1 (en) 2000-03-04 2003-04-17 Deem Mark E. Methods and devices for use in performing pulmonary procedures
AU2001239987A1 (en) 2000-03-06 2001-09-17 Tissuelink Medical, Inc. Fluid delivery system and controller for electrosurgical devices
US6558385B1 (en) 2000-09-22 2003-05-06 Tissuelink Medical, Inc. Fluid-assisted medical device
US6575929B2 (en) 2000-03-14 2003-06-10 Alcon Manufacturing, Ltd. Pumping chamber for a liquefaction handpiece
US6510854B2 (en) 2000-03-16 2003-01-28 Gyrus Medical Limited Method of treatment of prostatic adenoma
US6770070B1 (en) 2000-03-17 2004-08-03 Rita Medical Systems, Inc. Lung treatment apparatus and method
US6976950B2 (en) 2000-04-14 2005-12-20 Solace Therapeutics, Inc. Implantable valved pressure attenuation device
US6755794B2 (en) 2000-04-25 2004-06-29 Synovis Life Technologies, Inc. Adjustable stylet
AU2001257212B9 (en) 2000-04-25 2007-03-29 Impres Medical, Inc. Method and apparatus for creating intrauterine adhesions
US6652517B1 (en) 2000-04-25 2003-11-25 Uab Research Foundation Ablation catheter, system, and method of use thereof
US6488680B1 (en) 2000-04-27 2002-12-03 Medtronic, Inc. Variable length electrodes for delivery of irrigated ablation
ATE427711T1 (de) * 2000-05-03 2009-04-15 Bard Inc C R Gerat zur darstellung und ablation bei elektrophysiologischen verfahren
AU2001263239A1 (en) 2000-05-18 2001-11-26 Nuvasive, Inc. Tissue discrimination and applications in medical procedures
US6752805B2 (en) 2000-06-13 2004-06-22 Atrionix, Inc. Surgical ablation probe for forming a circumferential lesion
US6726708B2 (en) 2000-06-14 2004-04-27 Innercool Therapies, Inc. Therapeutic heating and cooling via temperature management of a colon-inserted balloon
US6716252B2 (en) 2000-06-30 2004-04-06 Wit Ip Corporation Prostatic stent with localized tissue engaging anchoring means and methods for inhibiting obstruction of the prostatic urethra
AU2001271043A1 (en) 2000-07-12 2002-01-21 Mitsubishi Pencil Kabushiki Kaisha Safe retained needle
US6647300B1 (en) 2000-07-28 2003-11-11 Rockwell Automation Technologies, Inc. Bidding partner cache for autonomous cooperative control system
US6679879B2 (en) * 2000-08-16 2004-01-20 John H. Shadduck Electrical discharge catheter system for extracting emboli in endovascular interventions
US6569146B1 (en) 2000-08-18 2003-05-27 Scimed Life Systems, Inc. Method and apparatus for treating saphenous vein graft lesions
US6669692B1 (en) * 2000-08-21 2003-12-30 Biosense Webster, Inc. Ablation catheter with cooled linear electrode
JP2002078809A (ja) 2000-09-07 2002-03-19 Shutaro Satake 肺静脈電気的隔離用バルーンカテーテル
US6551309B1 (en) 2000-09-14 2003-04-22 Cryoflex, Inc. Dual action cryoprobe and methods of using the same
US7031504B1 (en) * 2000-09-26 2006-04-18 Vital Images, Inc. Image data based retrospective temporal selection of medical images
US20030158545A1 (en) 2000-09-28 2003-08-21 Arthrocare Corporation Methods and apparatus for treating back pain
US6551300B1 (en) 2000-10-04 2003-04-22 Vidamed, Inc. Device and method for delivery of topically applied local anesthetic to wall forming a passage in tissue
US6585639B1 (en) 2000-10-27 2003-07-01 Pulmonx Sheath and method for reconfiguring lung viewing scope
US6527761B1 (en) 2000-10-27 2003-03-04 Pulmonx, Inc. Methods and devices for obstructing and aspirating lung tissue segments
US6455825B1 (en) 2000-11-21 2002-09-24 Sandia Corporation Use of miniature magnetic sensors for real-time control of the induction heating process
US7225040B2 (en) 2001-11-14 2007-05-29 Exxon Mobil Oil Corporation Method and system for reducing lead-time in the packaging industry
US9433457B2 (en) 2000-12-09 2016-09-06 Tsunami Medtech, Llc Medical instruments and techniques for thermally-mediated therapies
US7549987B2 (en) 2000-12-09 2009-06-23 Tsunami Medtech, Llc Thermotherapy device
US6681998B2 (en) 2000-12-22 2004-01-27 Chrysalis Technologies Incorporated Aerosol generator having inductive heater and method of use thereof
US20020087151A1 (en) 2000-12-29 2002-07-04 Afx, Inc. Tissue ablation apparatus with a sliding ablation instrument and method
WO2002056794A2 (fr) 2001-01-18 2002-07-25 The Brigham And Women's Hospital, Inc. Prothese pour patients atteints de troubles respiratoires
US6695839B2 (en) * 2001-02-08 2004-02-24 Oratec Interventions, Inc. Method and apparatus for treatment of disrupted articular cartilage
US7422586B2 (en) 2001-02-28 2008-09-09 Angiodynamics, Inc. Tissue surface treatment apparatus and method
US7087040B2 (en) 2001-02-28 2006-08-08 Rex Medical, L.P. Apparatus for delivering ablation fluid to treat lesions
US6666862B2 (en) 2001-03-01 2003-12-23 Cardiac Pacemakers, Inc. Radio frequency ablation system and method linking energy delivery with fluid flow
US7798147B2 (en) 2001-03-02 2010-09-21 Pulmonx Corporation Bronchial flow control devices with membrane seal
US20020177846A1 (en) * 2001-03-06 2002-11-28 Mulier Peter M.J. Vaporous delivery of thermal energy to tissue sites
US6623444B2 (en) 2001-03-21 2003-09-23 Advanced Medical Applications, Inc. Ultrasonic catheter drug delivery method and device
US6726696B1 (en) 2001-04-24 2004-04-27 Advanced Catheter Engineering, Inc. Patches and collars for medical applications and methods of use
US6551271B2 (en) 2001-04-30 2003-04-22 Biosense Webster, Inc. Asymmetrical bidirectional steerable catheter
WO2002089686A1 (fr) 2001-05-10 2002-11-14 Rita Medical Systems, Inc. Appareil et procede d'ablation tissulaire par rf
CA2447899A1 (fr) 2001-05-23 2002-11-28 Vital Images, Inc. Suppression d'occlusion destinee a un rendu volumique d'ordre d'objet
US6837884B2 (en) 2001-06-18 2005-01-04 Arthrocare Corporation Electrosurgical apparatus having compound return electrode
US6860847B2 (en) 2001-07-10 2005-03-01 Spiration, Inc. Constriction device viewable under X ray fluoroscopy
WO2003008034A1 (fr) 2001-07-18 2003-01-30 Ati Medical, Inc. Dispositifs et techniques de thermotherapie et de radiotherapie
CA2453410A1 (fr) 2001-07-27 2003-02-13 Wit Ip Corporation Methodes de traitement de la prostatite
US7130697B2 (en) 2002-08-13 2006-10-31 Minnesota Medical Physics Llc Apparatus and method for the treatment of benign prostatic hyperplasia
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
US6776765B2 (en) 2001-08-21 2004-08-17 Synovis Life Technologies, Inc. Steerable stylet
AU2002362310A1 (en) 2001-09-14 2003-04-01 Arthrocare Corporation Methods and apparatus for treating intervertebral discs
AU2002336575A1 (en) 2001-09-14 2003-04-01 Arthrocare Corporation Electrosurgical apparatus and methods for tissue treatment and removal
JP3607231B2 (ja) 2001-09-28 2005-01-05 有限会社日本エレクテル 高周波加温バルーンカテーテル
WO2003028542A2 (fr) 2001-10-02 2003-04-10 Arthrocare Corporation Appareil et procedes d'ablation et de digestion electrochirurgicales de tissu
US7342169B2 (en) 2001-10-05 2008-03-11 Nextreme Thermal Solutions Phonon-blocking, electron-transmitting low-dimensional structures
CA2458595C (fr) 2001-10-11 2007-12-04 Peter M. Wilson Dispositifs de commande d'ecoulement bronchique et procedes d'utilisation
US6905475B2 (en) 2001-10-12 2005-06-14 Ams Reseach Corporation Method of injecting a drug and echogenic bubbles into prostate tissue
US6592594B2 (en) 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US20030130738A1 (en) 2001-11-08 2003-07-10 Arthrocare Corporation System and method for repairing a damaged intervertebral disc
US7004941B2 (en) 2001-11-08 2006-02-28 Arthrocare Corporation Systems and methods for electrosurigical treatment of obstructive sleep disorders
US8444636B2 (en) 2001-12-07 2013-05-21 Tsunami Medtech, Llc Medical instrument and method of use
US6740081B2 (en) 2002-01-25 2004-05-25 Applied Medical Resources Corporation Electrosurgery with improved control apparatus and method
WO2003068311A2 (fr) 2002-02-13 2003-08-21 Arthrocare Corporation Appareil d'electrochirurgie et procedes de traitement de tissu d'articulation
US6929637B2 (en) 2002-02-21 2005-08-16 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
FR2836047B1 (fr) 2002-02-21 2004-04-02 Henri Mehier Installation destinee a la delivrance de calories dans tout ou partie d'un tissu cellulaire humain ou animal
US6896675B2 (en) 2002-03-05 2005-05-24 Baylis Medical Company Inc. Intradiscal lesioning device
US6528771B1 (en) * 2002-03-08 2003-03-04 The Boeing Company System and method for controlling an induction heating process
US20030181922A1 (en) 2002-03-20 2003-09-25 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US7128748B2 (en) 2002-03-26 2006-10-31 Synovis Life Technologies, Inc. Circular stapler buttress combination
US7288109B2 (en) 2002-04-04 2007-10-30 Innercool Therapies. Inc. Method of manufacturing a heat transfer element for in vivo cooling without undercuts
US8145316B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods and apparatus for renal neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US6955674B2 (en) 2002-04-11 2005-10-18 Medtronic, Inc. Medical ablation catheter control
JP2005522274A (ja) 2002-04-17 2005-07-28 スーパー ディメンション リミテッド 内視鏡構造と分岐構造内の標的にナビゲートするための技術
US7503904B2 (en) * 2002-04-25 2009-03-17 Cardiac Pacemakers, Inc. Dual balloon telescoping guiding catheter
US6780178B2 (en) 2002-05-03 2004-08-24 The Board Of Trustees Of The Leland Stanford Junior University Method and apparatus for plasma-mediated thermo-electrical ablation
US6588613B1 (en) 2002-05-13 2003-07-08 The United States Of America As Represented By The Secretary Of The Air Force Baby-feeding nipple
US6852108B2 (en) 2002-05-14 2005-02-08 Spiration, Inc. Apparatus and method for resecting and removing selected body tissue from a site inside a patient
WO2003099102A2 (fr) 2002-05-20 2003-12-04 Kevin Marchitto Dispositif et procede de cicatrisation et utilisations correspondantes
TWI328164B (en) 2002-05-29 2010-08-01 Tokyo Electron Ltd Method and apparatus for monitoring tool performance
US7462181B2 (en) 2002-06-04 2008-12-09 Stanford Office Of Technology Licensing Device and method for rapid aspiration and collection of body tissue from within an enclosed body space
US6967315B2 (en) 2002-06-12 2005-11-22 Steris Inc. Method for vaporizing a fluid using an electromagnetically responsive heating apparatus
US6734405B2 (en) 2002-06-12 2004-05-11 Steris Inc. Vaporizer using electrical induction to produce heat
CA2530042C (fr) 2002-06-17 2012-04-03 Aeris Therapeutics, Inc. Compositions et procedes pour reduire le volume pulmonaire
US6960203B2 (en) * 2002-06-26 2005-11-01 Ethicon, Inc. Thermal ablation with deployable cage
US6929642B2 (en) 2002-06-28 2005-08-16 Ethicon, Inc. RF device for treating the uterus
US7458967B2 (en) 2003-10-31 2008-12-02 Angiodynamics, Inc. Endovascular treatment apparatus and method
US6730079B2 (en) 2002-07-22 2004-05-04 Medtronic Vidamed, Inc. Method for calculating impedance and apparatus utilizing same
US6866662B2 (en) 2002-07-23 2005-03-15 Biosense Webster, Inc. Ablation catheter having stabilizing array
US6921385B2 (en) 2002-08-05 2005-07-26 Alcon, Inc. Apparatus for delivery of fluid to opthalmic surgical handpiece
WO2004022155A2 (fr) 2002-09-05 2004-03-18 Arthrocare Corporation Methodes et appareils permettant de traiter des disques intervertebraux
US7101367B2 (en) 2002-09-30 2006-09-05 Ethicon, Inc. Deployable cryosurgical catheter
US7004940B2 (en) 2002-10-10 2006-02-28 Ethicon, Inc. Devices for performing thermal ablation having movable ultrasound transducers
US7192400B2 (en) 2002-10-24 2007-03-20 Synovis Life Technologies, Inc. Device and method for vascular monitoring
US6905496B1 (en) 2002-11-01 2005-06-14 Alan G. Ellman RF electrosurgery cryogenic system
WO2004047616A2 (fr) 2002-11-21 2004-06-10 Hibler Timothy B Procede, systeme et dispositif medical cervical
US6918869B2 (en) 2002-12-02 2005-07-19 Scimed Life Systems System for administering a combination of therapies to a body lumen
AU2003297691A1 (en) 2002-12-03 2004-06-23 Arthrocare Corporation Devices and methods for selective orientation of electrosurgical devices
US6972014B2 (en) 2003-01-04 2005-12-06 Endocare, Inc. Open system heat exchange catheters and methods of use
US7083612B2 (en) 2003-01-15 2006-08-01 Cryodynamics, Llc Cryotherapy system
US7144588B2 (en) 2003-01-17 2006-12-05 Synovis Life Technologies, Inc. Method of preventing surgical adhesions
JP4067976B2 (ja) 2003-01-24 2008-03-26 有限会社日本エレクテル 高周波加温バルーンカテーテル
WO2004071278A2 (fr) 2003-02-05 2004-08-26 Arthrocare Corporation Appareil electrochirurgical d'indication thermique et methodes associees
AU2003303928A1 (en) 2003-02-14 2004-09-09 Alcon, Inc. Apparatus and method for determining that a surgical fluid container is near empty
AU2003301144A1 (en) 2003-02-14 2004-09-09 Alcon, Inc. Apparatus and method for determining that a surgical fluid container is near empty
US6875194B2 (en) 2003-02-25 2005-04-05 Alcon, Inc. Reduction or elimination of the introduction of air within fluid introduced into a surgical field
US20040230188A1 (en) 2003-05-12 2004-11-18 Iulian Cioanta Treatment catheters with thermally insulated regions
US20040230316A1 (en) 2003-05-12 2004-11-18 Iulian Cioanta Method for treating the prostate and inhibiting obstruction of the prostatic urethra using biodegradable stents
US7144402B2 (en) 2003-06-16 2006-12-05 Synovis Life Technologies, Inc. Vascular clamp
US7235070B2 (en) 2003-07-02 2007-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation fluid manifold for ablation catheter
US8012153B2 (en) 2003-07-16 2011-09-06 Arthrocare Corporation Rotary electrosurgical apparatus and methods thereof
US7220252B2 (en) 2003-07-18 2007-05-22 Polyzen, Inc. Inflatable dual balloon catheter
EP2316328B1 (fr) 2003-09-15 2012-05-09 Super Dimension Ltd. Dispositif de fixation à enroulement pour utilisation avec des bronchoscopes
ES2387026T3 (es) 2003-09-15 2012-09-11 Super Dimension Ltd. Dispositivo de fijación envolvente para utilizarse con broncoscopios
US7708733B2 (en) 2003-10-20 2010-05-04 Arthrocare Corporation Electrosurgical method and apparatus for removing tissue within a bone body
US7347859B2 (en) 2003-12-18 2008-03-25 Boston Scientific, Scimed, Inc. Tissue treatment system and method for tissue perfusion using feedback control
WO2005063136A2 (fr) 2003-12-22 2005-07-14 Ams Research Corporation Dispositifs cryochirurgicaux et methodes d'ablation endometriale
JP4391221B2 (ja) 2003-12-22 2009-12-24 有限会社日本エレクテル 高周波加温バルーンカテーテル
US7585295B2 (en) 2003-12-23 2009-09-08 Itos International Ltd. Thermal airflow tool and system
US6991028B2 (en) * 2004-01-29 2006-01-31 Comeaux Vernal J Thermal reservoir for two-pipe hydronic air-conditioning system
US7476242B2 (en) 2004-01-30 2009-01-13 Ams Research Corporation Electrically heated/phase change probe temperature control
US7727228B2 (en) 2004-03-23 2010-06-01 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
EP1738057B1 (fr) * 2004-04-23 2009-03-25 Shell Internationale Research Maatschappij B.V. Appareils electriques de chauffage souterrains utilisant une isolation a base de nitrure
CN1964757B (zh) 2004-04-23 2013-08-21 伦纳德·爱德华·福里斯特 用于治疗或排出椎间盘的装置
WO2006009688A2 (fr) 2004-06-16 2006-01-26 Pneumrx, Inc. Systeme de reduction de volume pulmonaire intra-bronchial
SE0401708D0 (sv) 2004-06-30 2004-06-30 Wallsten Medical Sa Balloon Catheter
AU2005258739B2 (en) 2004-07-07 2010-10-28 Covidien Lp Methods for localized intra-body treatment of tissue
EP1786502A2 (fr) 2004-07-15 2007-05-23 Incumed Dispositif et procede pour traiter un vaisseau sanguin
US20060047291A1 (en) 2004-08-20 2006-03-02 Uptake Medical Corporation Non-foreign occlusion of an airway and lung collapse
US20060130830A1 (en) 2004-09-07 2006-06-22 Uptake Medical Corporation Intra-bronchial implants for improved attachment
US20060085054A1 (en) * 2004-09-09 2006-04-20 Zikorus Arthur W Methods and apparatus for treatment of hollow anatomical structures
US7335197B2 (en) 2004-10-13 2008-02-26 Medtronic, Inc. Transurethral needle ablation system with flexible catheter tip
US7261709B2 (en) 2004-10-13 2007-08-28 Medtronic, Inc. Transurethral needle ablation system with automatic needle retraction
US7261710B2 (en) 2004-10-13 2007-08-28 Medtronic, Inc. Transurethral needle ablation system
US20060089636A1 (en) 2004-10-27 2006-04-27 Christopherson Mark A Ultrasound visualization for transurethral needle ablation
MX2007005937A (es) 2004-11-16 2007-09-11 Robert L Barry Metodo y aparato para tratamiento pulmonar.
CN2757751Y (zh) * 2004-12-22 2006-02-15 赵巧 实心子宫内膜消融器
FR2884149B1 (fr) 2005-04-12 2007-06-08 Henri Mehier Tube implantable destine a l'injection notamment de fluide caloporteur dans tout ou partie d'un tissu humain ou animal
US7546873B2 (en) 2005-04-22 2009-06-16 Shell Oil Company Low temperature barriers for use with in situ processes
CA2605720C (fr) 2005-04-22 2014-03-11 Shell Internationale Research Maatschappij B.V. Systeme de double barriere pour procede de conversion in situ
US8157815B2 (en) 2005-05-20 2012-04-17 Neotract, Inc. Integrated handle assembly for anchor delivery system
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US7896891B2 (en) 2005-05-20 2011-03-01 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US8945152B2 (en) 2005-05-20 2015-02-03 Neotract, Inc. Multi-actuating trigger anchor delivery system
US7909836B2 (en) 2005-05-20 2011-03-22 Neotract, Inc. Multi-actuating trigger anchor delivery system
US20060265031A1 (en) 2005-05-20 2006-11-23 Medtronic, Inc. Operation indicator for a portable therapy delivery device
US20070032785A1 (en) 2005-08-03 2007-02-08 Jennifer Diederich Tissue evacuation device
US7563010B2 (en) 2005-10-07 2009-07-21 Karl Storz Endovision, Inc. Endoscopic light source safety and control system with optical sensor
EP1941125A1 (fr) 2005-10-24 2008-07-09 Shell Oil Company Systèmes de cogénération et procédés de traitement de formations contenant des hydrocarbures
WO2007052341A1 (fr) 2005-11-01 2007-05-10 Japan Electel Inc. Systeme de catheter a ballonnet
CN100402005C (zh) * 2005-12-22 2008-07-16 尹格平 一种多功能妇科疾病热凝固治疗器具
US7713216B2 (en) 2006-04-10 2010-05-11 Intrapartum, Llc Method for cervical dilation and/or measurement
US20110077628A1 (en) * 2006-01-10 2011-03-31 Tsunami Medtech, Llc Medical system and method of use
US20070179496A1 (en) * 2006-01-31 2007-08-02 Medtronic, Inc. Flexible catheter for ablation therapy
US20070225750A1 (en) * 2006-03-10 2007-09-27 Brooke Ren Embolic protection systems
CA2649394C (fr) 2006-04-21 2015-11-24 Shell Internationale Research Maatschappij B.V. Ajustement de compositions d'alliages pour obtenir des proprietes choisies dans des systemes de chauffage a temperature limitee
JP4890991B2 (ja) 2006-07-31 2012-03-07 株式会社リコー 定着装置、これを用いた画像形成装置
US8298145B2 (en) * 2006-08-01 2012-10-30 Gynesonics, Inc. Peri-capsular fibroid treatment
EP2455035B1 (fr) 2006-10-18 2015-11-25 Vessix Vascular, Inc. Induction des effets de température souhaitables sur les tissus corporels
ES2407329T3 (es) 2006-10-18 2013-06-12 Vessix Vascular, Inc. Sistema para inducir efectos de temperatura deseables sobre un tejido corporal
US8585645B2 (en) 2006-11-13 2013-11-19 Uptake Medical Corp. Treatment with high temperature vapor
US7993323B2 (en) 2006-11-13 2011-08-09 Uptake Medical Corp. High pressure and high temperature vapor catheters and systems
US20080183036A1 (en) 2006-12-18 2008-07-31 Voyage Medical, Inc. Systems and methods for unobstructed visualization and ablation
US8475452B2 (en) * 2007-02-21 2013-07-02 Electromedical Associates, Llc Instruments and methods for thermal tissue treatment
US7896871B2 (en) 2007-02-22 2011-03-01 Medtronic, Inc. Impedance computation for ablation therapy
US20080275440A1 (en) 2007-05-03 2008-11-06 Medtronic, Inc. Post-ablation verification of lesion size
FR2915872B1 (fr) 2007-05-10 2009-07-10 Ct D Etude Et De Rech Medicale Installation destinee a l'injection de vapeur d'eau dans un vaisseau sanguin humain ou animal
US20080300571A1 (en) 2007-05-30 2008-12-04 Lepivert Patrick Process and device for selectively treating interstitial tissue
US20090125010A1 (en) 2007-07-06 2009-05-14 Sharkey Hugh R Uterine Therapy Device and Method
WO2009009398A1 (fr) 2007-07-06 2009-01-15 Tsunami Medtech, Llc Système médical et procédé d'utilisation
US8758366B2 (en) 2007-07-09 2014-06-24 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8197470B2 (en) 2007-08-23 2012-06-12 Aegea Medical, Inc. Uterine therapy device and method
EP2200526A1 (fr) * 2007-09-20 2010-06-30 Boston Scientific Scimed, Inc. Dispositif d'ablation thermique à main
US8322335B2 (en) 2007-10-22 2012-12-04 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
US8147532B2 (en) 2007-10-22 2012-04-03 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
US8251991B2 (en) 2007-11-14 2012-08-28 Halt Medical Inc. Anchored RF ablation device for the destruction of tissue masses
WO2009074844A1 (fr) 2007-12-12 2009-06-18 Vectec Manipulateur uterin a usage unique jetable et procede d'utilisation associe
US9924992B2 (en) 2008-02-20 2018-03-27 Tsunami Medtech, Llc Medical system and method of use
EP3622910A1 (fr) 2008-03-06 2020-03-18 AquaBeam LLC Ablation et cautérisation de tissus à l'aide de l'énergie optique véhiculée dans un courant de fluide
US8272383B2 (en) 2008-05-06 2012-09-25 Nxthera, Inc. Systems and methods for male sterilization
US8721632B2 (en) 2008-09-09 2014-05-13 Tsunami Medtech, Llc Methods for delivering energy into a target tissue of a body
US20090306640A1 (en) 2008-06-06 2009-12-10 Grant Michael Glaze Vein Therapy Device and Method
US8579888B2 (en) 2008-06-17 2013-11-12 Tsunami Medtech, Llc Medical probes for the treatment of blood vessels
JP2010002603A (ja) 2008-06-19 2010-01-07 Konica Minolta Business Technologies Inc 定着装置、及び画像形成装置
US8932207B2 (en) 2008-07-10 2015-01-13 Covidien Lp Integrated multi-functional endoscopic tool
US10736689B2 (en) 2008-08-20 2020-08-11 Prostacare Pty Ltd Low-corrosion electrode for treating tissue
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US9561066B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
EP2341859B1 (fr) 2008-10-06 2017-04-05 Virender K. Sharma Appareil d'ablation de tissus
WO2010054237A1 (fr) 2008-11-06 2010-05-14 Nxthera, Inc. Systèmes et méthodes de traitement de la bph
JP2012508067A (ja) 2008-11-06 2012-04-05 エヌエックスセラ インコーポレイテッド 前立腺組織の治療のためのシステム及び方法
EP2352452A4 (fr) 2008-11-06 2012-07-18 Nxthera Inc Systèmes et procédés de traitement de tissu prostatique
CA2733241C (fr) 2008-12-19 2016-08-16 Japan Electel Inc. Systeme catheter a ballon
US20100179416A1 (en) 2009-01-14 2010-07-15 Michael Hoey Medical Systems and Methods
US8388611B2 (en) 2009-01-14 2013-03-05 Nxthera, Inc. Systems and methods for treatment of prostatic tissue
US11284931B2 (en) 2009-02-03 2022-03-29 Tsunami Medtech, Llc Medical systems and methods for ablating and absorbing tissue
US8229588B2 (en) 2009-03-03 2012-07-24 Taiwan Semiconductor Manufacturing Company, Ltd. Method and system for tuning advanced process control parameters
US9833277B2 (en) 2009-04-27 2017-12-05 Nxthera, Inc. Systems and methods for prostate treatment
US20100298948A1 (en) 2009-04-27 2010-11-25 Michael Hoey Systems and Methods for Prostate Treatment
US8437870B2 (en) 2009-06-05 2013-05-07 Taiwan Semiconductor Manufacturing Company, Ltd. System and method for implementing a virtual metrology advanced process control platform
JP5318691B2 (ja) * 2009-07-27 2013-10-16 株式会社神戸製鋼所 多層盛溶接継手の低温靭性に優れた高強度格納容器用厚鋼板
US8900223B2 (en) 2009-11-06 2014-12-02 Tsunami Medtech, Llc Tissue ablation systems and methods of use
US9161801B2 (en) 2009-12-30 2015-10-20 Tsunami Medtech, Llc Medical system and method of use
AU2011230568B2 (en) 2010-03-25 2016-02-18 Boston Scientific Scimed, Inc. Systems and methods for prostate treatment
US9918787B2 (en) 2010-05-05 2018-03-20 St. Jude Medical, Atrial Fibrillation Division, Inc. Monitoring, managing and/or protecting system and method for non-targeted tissue
EP2568905A4 (fr) 2010-05-12 2017-07-26 Shifamed Holdings, LLC Assemblage d'électrode à faible profil
US9943353B2 (en) 2013-03-15 2018-04-17 Tsunami Medtech, Llc Medical system and method of use
US20120078078A1 (en) 2010-09-24 2012-03-29 C.R. Bard Means for securing a catheter into a vessel
TW201221165A (en) 2010-10-20 2012-06-01 Medtronic Ardian Luxembourg Catheter apparatuses having expandable mesh structures for renal neuromodulation and associated systems and methods
US20120232409A1 (en) 2010-12-15 2012-09-13 Stahmann Jeffrey E System and method for renal artery occlusion during renal denervation therapy
WO2012099974A2 (fr) 2011-01-19 2012-07-26 Fractyl Laboratories, Inc. Dispositifs et procédés de traitement de tissus
AU2012212492B2 (en) 2011-02-01 2016-05-12 Channel Medsystems, Inc. Methods and apparatus for cryogenic treatment of a body cavity or lumen
JP2012168403A (ja) 2011-02-15 2012-09-06 Ricoh Co Ltd 定着装置及び画像形成装置
US8512326B2 (en) 2011-06-24 2013-08-20 Arqos Surgical, Inc. Tissue extraction devices and methods
JP5853426B2 (ja) 2011-06-08 2016-02-09 東レ株式会社 バルーン付きアブレーションカテーテル
PT2755614T (pt) 2011-09-13 2018-01-18 Nxthera Inc Sistemas de tratamento da próstata
US20130116683A1 (en) 2011-11-09 2013-05-09 Tsunami Medtech, Llc Medical system and method of use
JP6441679B2 (ja) 2011-12-09 2018-12-19 メタベンション インコーポレイテッド 肝臓系の治療的な神経調節
KR102245697B1 (ko) 2012-02-27 2021-04-28 프랙틸 래브러토리스 인코포레이티드 조직의 치료를 위한 열 절제 시스템，장치 및 방법
WO2013152119A1 (fr) 2012-04-03 2013-10-10 Nxthera, Inc. Générateur de vapeur à bobine d'induction
US20130267939A1 (en) 2012-04-10 2013-10-10 Robert Lawrence Barry Methods and Apparatus for Ablating Lung Nodules with Vapor
JP5500273B1 (ja) 2012-07-05 2014-05-21 有限会社日本エレクテル バルーンカテーテルシステム
EP2945556A4 (fr) 2013-01-17 2016-08-31 Virender K Sharma Procédé et appareil d'ablation de tissu
US9179973B2 (en) 2013-03-15 2015-11-10 St. Jude Medical, Cardiology Division, Inc. Feedback systems and methods for renal denervation utilizing balloon catheter
AU2014251039B2 (en) 2013-04-08 2018-12-06 Apama Medical, Inc. Cardiac ablation catheters and methods of use thereof
WO2014197632A2 (fr) 2013-06-04 2014-12-11 Fractyl Laboratories, Inc. Procédés, systèmes et dispositifs pour réduire la surface luminale du tractus gastro-intestinal
US10952790B2 (en) 2013-09-13 2021-03-23 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
US9855089B2 (en) 2014-03-21 2018-01-02 Medtronic Cryocath Lp Shape changing ablation balloon
US9844641B2 (en) 2014-07-16 2017-12-19 Fractyl Laboratories, Inc. Systems, devices and methods for performing medical procedures in the intestine
CN114191067A (zh) 2016-05-19 2022-03-18 圣安娜技术有限公司 整合冷却的消融导管

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
US9700365B2 (en) 2017-07-11
EP3175805A1 (fr) 2017-06-07
CN102238920A (zh) 2011-11-09
EP2341859A4 (fr) 2013-01-16
US11020175B2 (en) 2021-06-01
US20160256214A9 (en) 2016-09-08
US20170231692A1 (en) 2017-08-17
US20100114083A1 (en) 2010-05-06
CN104739502B (zh) 2018-01-19
US20150119869A1 (en) 2015-04-30
US20100094270A1 (en) 2010-04-15
CN102238920B (zh) 2015-03-25
CN104739502A (zh) 2015-07-01
EP2341859A1 (fr) 2011-07-13
WO2010042461A1 (fr) 2010-04-15
US20210346088A1 (en) 2021-11-11
US20100114082A1 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
US20210346088A1 (en) Methods of Ablating Tissue Using Time-Limited Treatment Periods
US20210100600A1 (en) Method and Apparatus for Tissue Ablation
US11813014B2 (en) Methods and systems for directed tissue ablation
JP7311658B2 (ja) 一体化冷却を有するアブレーションカテーテル
US11589920B2 (en) Catheter with a double balloon structure to generate and apply an ablative zone to tissue
US20240108392A1 (en) Method and Apparatus for Tissue Ablation
US20210059749A1 (en) Systems and Methods for Ablating Prostate Tissue
US20230277238A1 (en) Catheter with a Double Balloon Structure to Generate and Apply a Heated Ablative Zone to Tissue

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110411

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121218

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 18/04 20060101AFI20121212BHEP

17Q First examination report despatched

Effective date: 20151028

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/107 20060101ALN20160621BHEP

Ipc: A61B 18/04 20060101AFI20160621BHEP

Ipc: A61B 18/00 20060101ALN20160621BHEP

Ipc: A61B 17/24 20060101ALN20160621BHEP

Ipc: A61B 17/00 20060101ALN20160621BHEP

Ipc: A61M 25/10 20060101ALN20160621BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160819

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAL Information related to payment of fee for publishing/printing deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

INTC Intention to grant announced (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 17/00 20060101ALN20170112BHEP

Ipc: A61M 25/10 20130101ALN20170112BHEP

Ipc: A61B 18/00 20060101ALN20170112BHEP

Ipc: A61B 18/04 20060101AFI20170112BHEP

Ipc: A61B 17/24 20060101ALN20170112BHEP

Ipc: A61B 5/107 20060101ALN20170112BHEP

GRAR Information related to intention to grant a patent recorded

Free format text: ORIGINAL CODE: EPIDOSNIGR71

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/107 20060101ALN20170223BHEP

Ipc: A61B 17/00 20060101ALN20170223BHEP

Ipc: A61B 18/04 20060101AFI20170223BHEP

Ipc: A61B 18/00 20060101ALN20170223BHEP

Ipc: A61B 17/24 20060101ALN20170223BHEP

Ipc: A61M 25/10 20130101ALN20170223BHEP

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

INTG Intention to grant announced

Effective date: 20170224

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 881046

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170415

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602009045288

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170405

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 881046

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170706

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170705

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170805

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170705

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009045288

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

26N No opposition filed

Effective date: 20180108

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171031

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171006

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171031

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20171031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171006

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171006

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20091006

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170405

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231024

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20231024

Year of fee payment: 15

Ref country code: DE

Payment date: 20231123

Year of fee payment: 15